<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v2.3 20070202//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName journalpublishing.dtd?><?SourceDTD.Version 2.3?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Iran J Basic Med Sci</journal-id><journal-id journal-id-type="iso-abbrev">Iran J Basic Med Sci</journal-id><journal-id journal-id-type="publisher-id">ijbms</journal-id><journal-title-group><journal-title>Iranian Journal of Basic Medical Sciences</journal-title></journal-title-group><issn pub-type="ppub">2008-3866</issn><issn pub-type="epub">2008-3874</issn><publisher><publisher-name>Mashhad University of Medical Sciences</publisher-name><publisher-loc>Mashhad, Iran</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">8061323</article-id><article-id pub-id-type="doi">10.22038/IJBMS.2020.50536.11512</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review Article</subject></subj-group></article-categories><title-group><article-title>Alzheimer&#x02019;s disease treatment: The share of herbal medicines</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Soheili</surname><given-names>Masoud</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Karimian</surname><given-names>Mohammad</given-names></name><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Hamidi</surname><given-names>Gholamali</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Salami</surname><given-names>Mahmoud</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref></contrib></contrib-group><aff id="aff1">
<label>1</label>Physiology Research Center, Institute for Basic Sciences, Kashan University of Medical Sciences, Kashan, Iran</aff><aff id="aff2">
<label>2</label>Department of Molecular and Cell Biology, Faculty of Basic Sciences, University of Mazandaran, Babolsar, Iran</aff><author-notes><corresp id="cor1"><label>*</label>Corresponding author: Mahmoud Salami. Physiology Research Center, Institute of Basic Sciences, Kashan University of Medical Sciences, Kashan, Iran. Tel: +98-361-5578010; Fax: +98-361-5578010; Email: salami-m@kaums.ac.ir</corresp></author-notes><pub-date pub-type="ppub"><month>2</month><year>2021</year></pub-date><volume>24</volume><issue>2</issue><fpage>123</fpage><lpage>135</lpage><history><date date-type="received"><day>18</day><month>7</month><year>2020</year></date><date date-type="accepted"><day>7</day><month>11</month><year>2020</year></date></history><permissions><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/3.0/</ali:license_ref><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License, (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/3.0/">http://creativecommons.org/licenses/by/3.0/</ext-link>) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><p>One of the most frequent forms of dementia in neurological disorders is Alzheimer&#x02019;s disease (AD). It is a chronic neurodegenerative disease characterized by impaired learning and memory. Pathological symptoms as extracellular amyloid-beta (A&#x003b2;) plaques and intracellular accumulation of neurofibrillary tangles occur in AD. Due to the aging of the population and increased prevalence of AD, discovery of new therapeutic agents with the highest effectiveness and fewer side effect seems to be necessary. Numerous synthetic medicines such as tacrine, donepezil, galantamine, rivastigmine, memantine, glutathione, ascorbic acid, ubiquinone, ibuprofen, and ladostigil are routinely used for reduction of the symptoms and prevention of disease progression. Nowadays, herbal medicines have attracted popular attention for numerous beneficial effects with little side effects. <italic>Lavandula angustifolia, Ginkgo biloba, Melissa officinalis, Crocus sativus, Ginseng, Salvia miltiorrhiza</italic>, and <italic>Magnolia officinalis </italic>have been widely used for relief of symptoms of some neurological disorders. This paper reviews the therapeutic effects of phytomedicines with prominent effects against various factors implicated in the emergence and progression of AD.</p></abstract><kwd-group><title>Key Words</title><kwd>Alzheimer&#x02019;s disease</kwd><kwd>Crocus sativus</kwd><kwd>Ginseng</kwd><kwd>Ginkgo biloba</kwd><kwd>Lavandula angustifolia</kwd><kwd>Magnolia officinalis</kwd><kwd>Melissa officinalis</kwd><kwd>Salvia miltiorrhiza</kwd></kwd-group></article-meta></front><body><sec sec-type="intro"><title>Introduction</title><p>Alzheimer&#x02019;s disease (AD) is known as an epidemic problem throughout the world. It is one of the frequent forms of dementia disorder with progressive synaptic damage and neuronal degeneration (<xref rid="B1" ref-type="bibr">1</xref>, <xref rid="B2" ref-type="bibr">2</xref>). There is a progressive increase in the prevalence of AD especially in ageing people such that about %4 of the populations have AD over the age of 65 and %47 after 85 years of age (<xref rid="B3" ref-type="bibr">3</xref>). The World Alzheimer Report in 2016 reported that about 47 million people are bearing physical, psychological, and behavioral problems related to AD, creating a heavy economic burden for both societies and healthcare providers (<xref rid="B4" ref-type="bibr">4</xref>).&#x000a0;</p><p>AD is characterized by learning and memory deficits, causing severe mental deterioration with social and occupational problems (<xref rid="B5" ref-type="bibr">5</xref>). The data acquisition and collection from the environment are known as learning, while programmed neural connections in the CNS leading to encoding, storing, and recovering information create memory (<xref rid="B6" ref-type="bibr">6</xref>, <xref rid="B7" ref-type="bibr">7</xref>). Both are associated with cognition that is impaired in AD people. The interactions between age, education, genetics, and environmental factors affect AD (<xref rid="B8" ref-type="bibr">8</xref>).&#x000a0;</p><p>There are two main types of AD according to the age of occurrence; early-onset or familial form in the young and late-onset or sporadic form after 65 years. The early onset of AD, the autosomal dominant inherited form, is a rapid progression type of disease with shorter survival time compared to the sporadic form (<xref rid="B9" ref-type="bibr">9</xref>). Usually, the patients have a history of AD in their family and are frequently associated with genetic causes. Sporadic AD, as a highly polygenic disease, has slow progression with a prevalence rate of &#x0003e; 95% in all AD cases (<xref rid="B10" ref-type="bibr">10</xref>). It occurs due to extracellular accumulation of the 42 amino acid peptide, called amyloid-beta (A&#x003b2;) plaque (see below), related to APP cleavage imperfection or deficit in A&#x003b2; clearance. Moreover, &#x003b5;4 isoform of Apolipoprotein E (Apo E4) is another significant genetic risk factor for sporadic form of AD. Apo E4 inhibits proteolytic degradation of A&#x003b2; through neprilysin (NEP) and insulin-degrading enzyme (IDE) activity (<xref rid="B11" ref-type="bibr">11</xref>).&#x000a0;</p><p>The main pathological features of AD are extracellular accumulation of A&#x003b2; plaques and intracellular formation of neurofibrillary tangles (NFT). In addition, glutamatergic and cholinergic dysfunction (<xref rid="B12" ref-type="bibr">12</xref>), oxidative stress (<xref rid="B13" ref-type="bibr">13</xref>), prion proteins (<xref rid="B14" ref-type="bibr">14</xref>), and inflammation (<xref rid="B15" ref-type="bibr">15</xref>) are implicated in the pathology of AD. </p><p>Today, herbal medicine has attracted the attention of researchers due to its more effective therapeutic aspects along with fewer side effects compared with synthetic drugs (<xref rid="B16" ref-type="bibr">16</xref>-<xref rid="B18" ref-type="bibr">18</xref>). Multifunctional effects have introduced them as a therapeutic strategy for the treatment of a wide range of diseases. In this study, we have focused on some medicinal herbs known to be suitable for the treatment of AD.</p><p>
<bold>Etiology of AD</bold>
</p><p>
<bold><italic>Amyloid-beta plaque</italic></bold>
</p><p>Extracellular accumulation of A&#x003b2; plaque is one of the main histopathological hallmarks of AD. It is normally produced in the brain and has an important role in cell signaling and synaptic plasticity (<xref rid="B19" ref-type="bibr">19</xref>). Sequential enzymatic action on the transmembrane amyloid precursor protein (APP) by &#x003b2;- and &#x003b3;-secretases causes A&#x003b2; generation (<xref rid="B20" ref-type="bibr">20</xref>). During aging, because of mutation in APP or related cleavage enzymes, including secretases and presenilin family, there is an overproduction of A&#x003b2; as well as a deficiency in its clearance, resulting in peptide aggregation and plaque formation (<xref rid="B21" ref-type="bibr">21</xref>). Excessive amount of A&#x003b2; fibrils induces neurotoxicity and synaptotoxicity, dysfunction, and degeneration of neurons and ultimately neuronal death (<xref rid="B20" ref-type="bibr">20</xref>). It also induces some abnormalities in brain metabolic processes leading to neuroinflammation (<xref rid="B22" ref-type="bibr">22</xref>).&#x000a0;There are several different ways including microglial and macrophage phagocytosis, transcytosis across the blood-brain barrier (BBB), autophagy, and proteolytic degradation to clear A&#x003b2; from the brain (<xref rid="B23" ref-type="bibr">23</xref>). The ability of some degrading enzymes such as metalloendopeptidase, NEP, and IDE in the clearance of A&#x003b2; has also been demonstrated (<xref rid="B24" ref-type="bibr">24</xref>).</p><p>
<bold><italic>Neurofibrillary tangles </italic></bold>
</p><p>Neurofibrillary tangles are another fundamental neuropathological hallmark of AD. They are generated by hyperphosphorylation of the cytoskeletal microtubules associated protein called tau protein (<xref rid="B25" ref-type="bibr">25</xref>). Normally, tau proteins stabilize microtubules in neuronal pathways, however, in AD patients, hyperphosphorylation of tau proteins leads to formation of paired helical NFT filaments that stimulate host neuronal cell death (<xref rid="B26" ref-type="bibr">26</xref>). It is revealed that A&#x003b2; stimulates phosphorylation of tau and, therefore, provokes formation of NFT (<xref rid="B27" ref-type="bibr">27</xref>). Formation of NFT correlates with functional impairment, cognitive decline, and neurodegeneration especially in AD (<xref rid="B28" ref-type="bibr">28</xref>).</p><p>
<bold><italic>Neurotransmission dysfunction</italic></bold>
</p><p>
<bold><italic>Glutamatergic&#x000a0;system&#x000a0;</italic></bold>
</p><p>Glutamate is the most important excitatory neurotransmitter in the brain which is involved in different mechanisms of synaptic plasticity, the necessary process for encoding learning and memory phenomena (<xref rid="B29" ref-type="bibr">29</xref>). Dysfunction of the ionotropic N-methyl-D-aspartate (NMDA) glutamate receptor is importantly implicated in the neuronal excitotoxicity in AD (<xref rid="B30" ref-type="bibr">30</xref>). In late onset AD, A&#x003b2; can directly bind to the NMDA receptors, leading to increased extracellular glutamate concentration and excessive activation of the receptor (<xref rid="B31" ref-type="bibr">31</xref>). Overactivity of NMDA receptors itself disrupts Ca<sup>2+</sup> influx leading to un-regulated intracellular signaling and neurotoxicity; a pathological mechanism recognized in some neurodegenerative disorders, including AD (<xref rid="B32" ref-type="bibr">32</xref>). It is also shown that A&#x003b2; oligomers have a toxic impact on glucose metabolism via AMP-activated kinase (AMPK). An impaired AMPK destroys synaptic plasticity through NMDA receptors which (<xref rid="B33" ref-type="bibr">33</xref>). In an A&#x003b2; independent manner, Apo E4 can occupy the NMDA receptors and impair synaptic plasticity in AD (<xref rid="B34" ref-type="bibr">34</xref>).</p><p>
<bold><italic>Cholinergic system</italic></bold>
</p><p>Acetylcholine (ACh) abundantly occurs in the brain synapses and is essential for brain processing and memory formation. It is synthesized and degraded by choline acetyltransferase and acetylcholinesterase enzymes, respectively (<xref rid="B35" ref-type="bibr">35</xref>). The level of ACh is shown to be declined in the cognition and memory relevant areas of the brain such as the cortex and hippocampus (<xref rid="B36" ref-type="bibr">36</xref>). Also, documents indicate that dysfunction of the cholinergic system is responsible for short-term memory deficit in AD (<xref rid="B37" ref-type="bibr">37</xref>). Importantly, in the latest stages of AD, due to decreased synthesis and increased degradation of ACh, the levels of the neurotransmitters decline by up to 85%.&#x000a0;</p><p>Cholinesterase enzymes that hydrolyze ACh exist in both neuronal and non-neuronal tissues; they are classified as acetylcholinesterase (AChE) and butyrylcholinesterase (BchE). Overactivity of AChE and BChE reduces ACh and disrupts the cholinergic system (<xref rid="B38" ref-type="bibr">38</xref>). Clinical evidence also shows that AChE can promote production and deposition of A&#x003b2; in AD patients (<xref rid="B39" ref-type="bibr">39</xref>). BchE, known as pseudocholinesterase, is a nonspecific <ext-link ext-link-type="uri" xlink:href="https://en.wikipedia.org/wiki/Cholinesterase">cholinesterase</ext-link> enzyme involved in hydrolyzing of different types of choline esters. It is primarily associated with glial cells and endothelial cells in the brain with a minor role in regulation of brain ACh levels (<xref rid="B40" ref-type="bibr">40</xref>).</p><p>
<bold><italic>Oxidative stress</italic></bold>
</p><p>Oxidative stress is another mechanism through which the possibility of AD occurrence will be increased. Oxidative stressors cause damage to DNA, proteins, and other macromolecules (<xref rid="B41" ref-type="bibr">41</xref>). They cause mitochondrial dysfunction leading to excessive production of oxidative agents such as reactive oxygen species (ROS) and free radicals, leading to neurotoxic events (<xref rid="B42" ref-type="bibr">42</xref>) and autophagic degradation of mitochondria in AD people (<xref rid="B43" ref-type="bibr">43</xref>).&#x000a0;Oxidative stress stimulates lipid peroxidation, a process that leads to formation of some reactive aldehydes like <ext-link ext-link-type="uri" xlink:href="https://en.wikipedia.org/wiki/Malondialdehyde">malondialdehyde</ext-link> (MDA) and&#x000a0;<ext-link ext-link-type="uri" xlink:href="https://en.wikipedia.org/wiki/4-hydroxynonenal">4-hydroxynonenal</ext-link>. They are known as major bioactive markers of lipid peroxidation and act as ROS. It is proven that the lipid peroxidation by-products play an important role in AD pathogenesis (<xref rid="B44" ref-type="bibr">44</xref>, <xref rid="B45" ref-type="bibr">45</xref>). Plenty of studies have shown that many of the pathological symptoms of AD occur due to oxidative stress, which promotes the initiation and progression of AD (<xref rid="B46" ref-type="bibr">46</xref>-<xref rid="B48" ref-type="bibr">48</xref>). Indeed, a category of the proposed drugs treating AD are anti-oxidants which scavenge free radicals and prevent cells from damage (<xref rid="B49" ref-type="bibr">49</xref>).&#x000a0;</p><p>
<bold><italic>Prion proteins</italic></bold>
</p><p>Another effective mechanism involved in AD is prion (PrPc). This cell surface glycoprotein is found in neurons especially in the spinal cord (<xref rid="B50" ref-type="bibr">50</xref>). The normal function of PrPc is enigmatic but it seems that the PrPc acts as an anti-apoptotic and anti-oxidant protein (<xref rid="B51" ref-type="bibr">51</xref>). The expression of PrPc is regulated by the amyloid intracellular domain. PrPc reduces beta-secretase (BACE1) activity and prevents overproduction of the A&#x003b2; peptide. In AD patients, this interaction is disrupted, resulting in overactivity of BACE1, which in turn, leads to extra production of A&#x003b2; peptide (<xref rid="B52" ref-type="bibr">52</xref>). On the other hand, by binding to the ends of growing polymers, PrPc has an inhibitory effect on fibril elongation of A&#x003b2;. Interaction of A&#x003b2; oligomers with mutated PrPc plays a destructive effect on synaptic transmission (<xref rid="B53" ref-type="bibr">53</xref>) and inhibits memory consolidation (<xref rid="B54" ref-type="bibr">54</xref>).&#x000a0;</p><p>
<bold><italic>Neuroinflammation</italic></bold>
</p><p>Immunopathological investigations have proven that inflammatory mediators are increased in AD. High levels of complement proteins and acute phase reactants are detected in the brain of AD patients. Also transforming growth factor &#x000df; (TGF-&#x000df;), an anti-inflammatory cytokine that also regulates brain inflammatory mediators, is up-regulated in AD (<xref rid="B55" ref-type="bibr">55</xref>).&#x000a0;</p><p>Cyclooxygenase (COX) is a key enzyme responsible for brain inflammation in AD patients. It is shown that non-steroidal anti-inflammatory (NSAIDs) drugs play their anti-inflammatory role by inhibition of COX ll. Also, in AD patients, the amount of C-reactive protein and IL-6, as inflammation biomarkers, is considerably higher than in normal people, particularly in the early stages of the disease (<xref rid="B56" ref-type="bibr">56</xref>).&#x000a0;</p><p>Another important progressive biomarker of AD is the serum amyloid P component (SAP) which is produced in the liver and localized in the brain. SAP is a neurotoxic agent that, through binding to fibrils, protects A&#x003b2; from proteolysis. With disease progression, more cytokines and acute-phase proteins are released and, thus, more A&#x003b2; fibrils will be deposited (<xref rid="B57" ref-type="bibr">57</xref>, <xref rid="B58" ref-type="bibr">58</xref>).&#x000a0;</p><p>
<bold>Current therapeutic methods</bold>
</p><p>Obviously, there are no absolute medications to reverse neuronal and synaptic destruction in AD (<xref rid="B59" ref-type="bibr">59</xref>), and currently approved drugs only alleviate clinical symptoms. The routine drugs for AD are cholinesterase inhibitors (<xref rid="B60" ref-type="bibr">60</xref>), NMDA receptor antagonists (<xref rid="B61" ref-type="bibr">61</xref>), and anti-oxidant and anti-inflammatory agents (<xref rid="B62" ref-type="bibr">62</xref>). These chemical synthetic drugs have various adverse effects such as nausea, diarrhea, bradycardia, and hepatotoxicity (<xref rid="B63" ref-type="bibr">63</xref>). Cholinesterase inhibitors such as tacrine, donepezil, galantamine, and rivastigmine are able to inhibit AChE, increase ACh concentration, and improve cognitive function (<xref rid="B64" ref-type="bibr">64</xref>, <xref rid="B65" ref-type="bibr">65</xref>). Memantine, as a glutamate receptor antagonist, reduces A&#x003b2; deposition and disaggregates A&#x003b2; fibrils and thus, prevents neurotoxic effects. It also reduces neuronal cell death via Ca<sup>2+</sup> influx regulation (<xref rid="B66" ref-type="bibr">66</xref>). Anti-oxidant agents such as glutathione, ascorbic acid, and ubiquinone scavenge free radicals and chelate metal ions, as well as preventing cell damage by ROS neutralization (<xref rid="B67" ref-type="bibr">67</xref>, <xref rid="B68" ref-type="bibr">68</xref>). NSAIDs such as ibuprofen have a protective effect against the incidence of AD (<xref rid="B69" ref-type="bibr">69</xref>). Also, ladostigil is a chemical neuroprotective, anti-inflammatory, and neurogenesis inducing agent that is able to slow down the progression of mild cognitive impairment to AD (<xref rid="B70" ref-type="bibr">70</xref>, <xref rid="B71" ref-type="bibr">71</xref>). Interestingly, in addition to synthetic drugs, current knowledge recommends the use of micronutrients (<xref rid="B69" ref-type="bibr">69</xref>, <xref rid="B70" ref-type="bibr">70</xref>), supplements (<xref rid="B73" ref-type="bibr">73</xref>-<xref rid="B71" ref-type="bibr">71</xref>), and herbal medicines to relieve AD symptoms.</p><p>
<bold>Traditional phytomedicine</bold>
</p><p>In parallel to increasing concerns about the side effects of synthetic drugs, the tendency to use herbal medicines is growing. Although popularity of traditional treatment varies in different countries, the therapeutic role of herbs is under consideration worldwide (<xref rid="B16" ref-type="bibr">16</xref>, <xref rid="B18" ref-type="bibr">18</xref>, <xref rid="B72" ref-type="bibr">72</xref>). It is for a long time that herbal medicines have been used for the relief of brain disorders including AD (<xref rid="B17" ref-type="bibr">17</xref>, <xref rid="B73" ref-type="bibr">73</xref>). In this context, albeit scant, attempts have been made to examine if herbal medicines have a considerable role in the treatment of AD. Here, we review recent findings from animal and clinical research about protective and therapeutic effects of several herbal medicines on AD. Behavioral, biochemical, cellular, and molecular aspects of investigations are considered. Henceforth, we evaluate the characteristics of some available and routinely used herbal medicines and their role in the treatment of AD.</p><p>
<bold><italic>Lavandula angustifolia Mill.</italic></bold>
</p><p>
<italic>Lavandula angustifolia</italic> (lavender ) is a native aromatic shrub in the Mediterranean region that belongs to the <italic>Lamiacea</italic>e family (<xref rid="B74" ref-type="bibr">74</xref>, <xref rid="B75" ref-type="bibr">75</xref>). Different extract forms of this plant including essential oil, aqueous extract, alcoholic extract, hydroalcoholic extract, and phenolic extract have been used in traditional treatment. While the main constituents of the essential oil of lavender are linalool and linalyl acetate, aqueous extract of lavender primarily consists of caffeic acid and luteolin (<xref ref-type="fig" rid="F1">Figure 1</xref>) (<xref rid="B76" ref-type="bibr">76</xref>, <xref rid="B77" ref-type="bibr">77</xref>). Our study indicated that the aqueous extract of lavender has no toxic effect on the Hep G2 cell line (<xref rid="B75" ref-type="bibr">75</xref>).</p><p>Numerous characteristics of herbal drugs such as anti-inflammatory (<xref rid="B78" ref-type="bibr">78</xref>) and anti-oxidant activities (<xref rid="B79" ref-type="bibr">79</xref>), inhibition of glutamate-induced neurotoxicity (<xref rid="B80" ref-type="bibr">80</xref>), prevention of A&#x003b2; polymerization (<xref rid="B73" ref-type="bibr">73</xref>),&#x000a0; anti-oxidant properties (<xref rid="B77" ref-type="bibr">77</xref>), and AChE inhibitory effect (<xref rid="B80" ref-type="bibr">80</xref>) have encouraged researchers to focus on lavender as a candidate medicine for the treatment of AD.&#x000a0;</p><p>It is reported that treatment of rat pups&#x02019; cerebellar granular cell culture with aqueous extract of lavender diminishes glutamate-induced neurotoxicity (<xref rid="B76" ref-type="bibr">76</xref>). It is shown that, via scavenging free radicals, lavender aqueous extract displays a potent anti-oxidant effect (<xref rid="B77" ref-type="bibr">77</xref>).&#x000a0;</p><p>In the level of neuronal activity, administration of aqueous extract of lavender in the A&#x003b2; injected rats restored deteriorated plasticity of hippocampal glutamatergic synaptic transmission (<xref rid="B1" ref-type="bibr">1</xref>). Also, intracerebroventricular injection of A&#x003b2; altered hippocampal protein expression in the hippocampus (<xref rid="B81" ref-type="bibr">81</xref>). Importantly, in an <italic>in vitro </italic>study using an atomic force microscope, we found that aqueous extract of lavender dose-dependently inhibits polymerization of A&#x003b2; monomer and prevents thickening of the A&#x003b2; fibrils (<xref rid="B77" ref-type="bibr">77</xref>). Further, histological assessment proved that lavender aqueous extract substantially clears brain A&#x003b2; plaques in the rat model of AD (<xref rid="B82" ref-type="bibr">82</xref>).&#x000a0;In our previous study, using a Morris water maze task, we showed that aqueous extract of lavender improves impaired spatial learning and memory in an animal model of AD (<xref rid="B5" ref-type="bibr">5</xref>). A clinical trial, reported that lavender significantly reduced physical non-aggressive behaviors in patients with the dementia disorder (<xref rid="B83" ref-type="bibr">83</xref>). Metabolomic analysis of serum collected from the AD model of rats, receiving aqueous extract of lavender, showed that the extract restores metabolic profile of AD treated animals to normal status (<xref rid="B84" ref-type="bibr">84</xref>).&#x000a0;</p><p>Despite behavioral, electrophysiological, and histological evaluations confirming the favorable effect of lavender on the treatment of AD, due to different constituents of oil based, alcoholic, and aqueous extracts of lavender, caution must be exercised in using the herbal medicine. For instance, while the aqueous extract of lavender inhibits polymerization of the A&#x003b2; monomer, its essential oil promotes the formation of A&#x003b2; fibrils (<xref rid="B73" ref-type="bibr">73</xref>).&#x000a0;</p><p>
<bold><italic>Ginkgo biloba</italic></bold>
</p><p>
<italic>Ginkgo biloba</italic>, or ginkgo, is a large tree with an angular <ext-link ext-link-type="uri" xlink:href="https://en.wikipedia.org/wiki/Crown_(botany)">crown</ext-link>&#x000a0;and long erratic branches. This well-known traditional Chinese therapeutic herb has multi-functional effects. It has been used for thousands of years in folk medicine to treat a wide range of diseases (<xref rid="B86" ref-type="bibr">86</xref>). Several clinical investigations on AD patients validated the improving effect of <italic>G. biloba</italic> on cognitive impairment and disease progression especially in the early stages (<xref rid="B87" ref-type="bibr">87</xref>-<xref rid="B89" ref-type="bibr">89</xref>). It is shown that <italic>G. biloba</italic> can normalize ACh receptors in the hippocampus and stimulate the neurotransmitter activity leading to improvement of learning and memory in AD (<xref rid="B90" ref-type="bibr">90</xref>). A study showed the strong AChE inhibitory activity of <italic>G. biloba</italic> (<xref rid="B91" ref-type="bibr">91</xref>). The <italic>G. biloba</italic> extract protects brain cells against toxicity related to A&#x003b2; plaques (<xref rid="B92" ref-type="bibr">92</xref>) and affects some A&#x003b2;-induced events including ROS generation and accumulation, mitochondrial dysfunction, and apoptosis (<xref rid="B92" ref-type="bibr">92</xref>-<xref rid="B94" ref-type="bibr">94</xref>). Herbal medicine also inhibits free cholesterol circulation and interferes with A&#x003b2; synthesis (<xref rid="B95" ref-type="bibr">95</xref>). Consistently, research found that extract of the plant prevents <italic>in vitro</italic> A&#x003b2; oligomerization and fibril formation (<xref rid="B93" ref-type="bibr">93</xref>). Some evidence indicates that <italic>G. biloba</italic> can inhibit A&#x003b2; production by stimulation of the gamma-secretase pathway in the APP cleavage process (<xref rid="B96" ref-type="bibr">96</xref>). Moreover, <italic>G. biloba</italic> can protect astrocytes of rat hippocampus (<xref rid="B97" ref-type="bibr">97</xref>) and displays a neuroprotective effect through regulation of tau phosphorylation, elimination of amyloid plaques (<xref rid="B98" ref-type="bibr">98</xref>), induction of growth factors synthesis, and calcium homeostasis (<xref rid="B99" ref-type="bibr">99</xref>).&#x000a0;</p><p>The free radical scavenging effect of <italic>G. biloba</italic> has been proven by numerous <italic>in vitro</italic> and <italic>in vivo</italic> studies (<xref rid="B94" ref-type="bibr">94</xref>, <xref rid="B100" ref-type="bibr">100</xref>-<xref rid="B103" ref-type="bibr">103</xref>). The medicinal plant increases the activity of anti-oxidant enzymes such as s<ext-link ext-link-type="uri" xlink:href="https://en.wikipedia.org/wiki/Superoxide_dismutase">uperoxide dismutase </ext-link>(SOD) and catalase (<xref rid="B101" ref-type="bibr">101</xref>).&#x000a0;</p><p>Glutathione (GSH) is a critical anti-oxidant agent in humans, <ext-link ext-link-type="uri" xlink:href="https://en.wikipedia.org/wiki/Animals">animals</ext-link>, <ext-link ext-link-type="uri" xlink:href="https://en.wikipedia.org/wiki/Plants">plants</ext-link>,&#x000a0;<ext-link ext-link-type="uri" xlink:href="https://en.wikipedia.org/wiki/Fungi">fungi</ext-link>, and some <ext-link ext-link-type="uri" xlink:href="https://en.wikipedia.org/wiki/Bacteria">bacteria</ext-link>&#x000a0;and&#x000a0;<ext-link ext-link-type="uri" xlink:href="https://en.wikipedia.org/wiki/Archaea">archaea</ext-link>. It is produced by the reduction of glutathione disulfide to sulfhydryl form of GSH enhanced by glutathione reductase. GSH is capable of preventing oxidative stress damage to cellular components.&#x000a0; It is proven that <italic>G. biloba</italic> enhances the activity of glutathione reductase and stimulates generation of GSH (<xref rid="B104" ref-type="bibr">104</xref>, <xref rid="B105" ref-type="bibr">105</xref>). Another important mechanism implicated in various neurodegenerative diseases is the apoptotic pathway. It is reported that, through maintenance of mitochondrial membrane integrity and inhibition of cytochrome c releasing, <italic>G. biloba</italic> appears as an anti-apoptotic agent (<xref rid="B101" ref-type="bibr">101</xref>, <xref rid="B102" ref-type="bibr">102</xref>, <xref rid="B106" ref-type="bibr">106</xref>).&#x000a0; It prevents formation of the pre-apoptotic complexes and related caspase cascade.</p><p>Plentiful evidence indicated that ginkgolide (<xref ref-type="fig" rid="F2">Figure 2</xref>) and flavonoids, as biological terpenic lactone components of this herb, display very specific and potent anti-inflammatory effects through antagonist activity on platelet-activating factor, a regulator of pro-inflammatory cytokines synthesis (<xref rid="B107" ref-type="bibr">107</xref>).&#x000a0;</p><p>Some other neuroprotective effects of <italic>G. biloba</italic> are protection against H<sub>2</sub>O<sub>2</sub>, NO, glutamate-induced toxicity, and hypoxia, as demonstrated in cultured neurons (<xref rid="B108" ref-type="bibr">108</xref>).&#x000a0;</p><p>
<bold><italic>Melissa officinalis</italic></bold>
</p><p>
<italic>Melissa officinalis</italic>, also called lemon balm, belongs to the <italic>Lamiaceae</italic> family. This plant has small white <ext-link ext-link-type="uri" xlink:href="https://en.wikipedia.org/wiki/Flower">flower</ext-link>s during summer and leaves with a mild <ext-link ext-link-type="uri" xlink:href="https://en.wikipedia.org/wiki/Lemon">lemon</ext-link>&#x000a0;scent. This phytomedicine is used to ameliorate motivation and behavior in patients with dementia disorder (<xref rid="B107" ref-type="bibr">107</xref>). Anti-oxidant (<xref rid="B110" ref-type="bibr">110</xref>, <xref rid="B111" ref-type="bibr">111</xref>), anti-depressant (<xref rid="B112" ref-type="bibr">112</xref>), anxiolytic (<xref rid="B112" ref-type="bibr">112</xref>), and anti-inflammatory (<xref rid="B113" ref-type="bibr">113</xref>) activities are attributed to this plant. The therapeutic effects of this herbal medicine are due to its main active constituents: triterpenes, phenolic acids, and flavonoids (<xref rid="B114" ref-type="bibr">114</xref>).</p><p>A Study by Lopez <italic>et al.</italic> confirmed that the aqueous and methanol extracts of <italic>M. officinalis</italic> diminish intracellular ROS generation (<xref rid="B115" ref-type="bibr">115</xref>). A study showed that some derivatives of <italic>M. officinalis</italic> such as flavonoids, caffeic acid, and rosmaric acid have anti-oxidant properties (<xref rid="B116" ref-type="bibr">116</xref>). It is demonstrated that medicine plays a potent anti-oxidant role through decreasing MDA (<xref rid="B117" ref-type="bibr">117</xref>), increasing GSH (<xref rid="B118" ref-type="bibr">118</xref>), and Paraoxonase 1, as critical enzymes in detoxifying oxidative stress mediators (<xref rid="B117" ref-type="bibr">117</xref>). It also displays anti-oxidant activity by scavenging free radicals, inhibiting lipid peroxidation, and protecting against H<sub>2</sub>O<sub>2</sub> (<xref rid="B119" ref-type="bibr">119</xref>).&#x000a0;</p><p>It is reported that <italic>M. officinalis</italic> diminishes agitation and physical non-aggressive behavior in aged people (<xref rid="B120" ref-type="bibr">120</xref>) and modulates cognitive performance in healthy young volunteers (<xref rid="B121" ref-type="bibr">121</xref>). Soodi <italic>et al.</italic> demonstrated that the ethanol extract of <italic>M. officinalis</italic> enhances improvement of learning and memory in the scopolamine model of dementia. They attributed this cognitive supporting action to its inhibitory effect on AChE activity (<xref rid="B122" ref-type="bibr">122</xref>). <italic>M. officinalis</italic> alleviates neuronal excitability and improves cognitive dysfunction in AD patients (<xref rid="B123" ref-type="bibr">123</xref>). Research indicates that through affecting the serotonergic system and ligand-gated and ion channels, <italic>M. officinalis</italic> improves some symptoms in AD people (<xref rid="B120" ref-type="bibr">120</xref>, <xref rid="B124" ref-type="bibr">124</xref>). Research proved that gallic acid, as an important constituent of <italic>M. officinalis</italic>, can reduce matrix metalloproteinase-2 activity that is involved in AD (<xref rid="B125" ref-type="bibr">125</xref>). The medicinal plant also shows a neuroprotective effect through reduction of A&#x003b2; induced neurotoxicity (<xref rid="B126" ref-type="bibr">126</xref>).</p><p>Taken together, different pharmaceutical effects of <italic>M. officinalis</italic> especially anti-cholinesterase, anti-oxidant, and anti-neurotoxicity activities have made herbal medicine an appropriate candidate for relieving symptoms of neurodegenerative diseases such as AD. </p><p>
<bold><italic>Crocus sativus&#x000a0;</italic></bold>
</p><p>
<italic>Crocus sativus</italic>, a species of <italic>Iridaceae</italic> family that is called saffron as well, has been widely used in traditional medicine. Anti-inflammatory (<xref rid="B127" ref-type="bibr">127</xref>), radical scavenging (<xref rid="B128" ref-type="bibr">128</xref>), and neuroprotective effects (<xref rid="B129" ref-type="bibr">129</xref>) are attributed to this herbal plant. The main sources of anti-oxidant activity of saffron are phenolic and carotenoids compounds (<xref rid="B130" ref-type="bibr">130</xref>). Most saffron effects, in fact, belong to one of the main active phytochemical ingredients called crocin (<xref ref-type="fig" rid="F3">Figure 3</xref>) (<xref rid="B131" ref-type="bibr">131</xref>). Crocin plays multi pharmacological activities such as anti-oxidant (<xref rid="B129" ref-type="bibr">129</xref>), inhibition of peroxidized lipids formation (<xref rid="B132" ref-type="bibr">132</xref>), SOD activity restoration (<xref rid="B133" ref-type="bibr">133</xref>), neuronal protection (<xref rid="B134" ref-type="bibr">134</xref>), and neuron morphology preservation (<xref rid="B135" ref-type="bibr">135</xref>). This low stability compound is able to remove ROS powerfully (<xref rid="B136" ref-type="bibr">136</xref>). Experimental evidence proves the positive effect of crocin on memory and cognition improvement (<xref rid="B137" ref-type="bibr">137</xref>, <xref rid="B138" ref-type="bibr">138</xref>), as well as plasticity of synaptic transmission in the neural circuits (<xref rid="B139" ref-type="bibr">139</xref>), a neural mechanism involved in learning and memory phenomena. This stemless flowering plant is shown to be effective in the treatment of mild to moderate depression (<xref rid="B140" ref-type="bibr">140</xref>) and mental illnesses (<xref rid="B139" ref-type="bibr">139</xref>).</p><p>Via suppression of inflammatory cytokines, <italic>C. sativus</italic> demonstrates anti-inflammatory properties. The attenuating effect of saffron extract on the production and deposition of A&#x003b2; in the hippocampus has been verified (<xref rid="B141" ref-type="bibr">141</xref>). It enhances up-regulation of lipoprotein receptor-related protein 1 and NEP enzymes. It can stimulate A&#x003b2; clearance by decreasing the tightness of BBB. It is found that, through anti-amyloidogenic activity (<xref rid="B142" ref-type="bibr">142</xref>) and anti-A&#x003b2; fibrilization (<xref rid="B143" ref-type="bibr">143</xref>), saffron plays an important role in the prevention of A&#x003b2; plaque formation in AD.</p><p>
<bold><italic>Panax&#x000a0;ginseng</italic></bold>
</p><p>
<italic>Panax Ginseng</italic> is the root of a plant in the <italic>Panax</italic> genus that belongs to the <italic>Araliaceae</italic> family. It occupies a special place in ancient medicinal treatment (<xref rid="B144" ref-type="bibr">144</xref>). This hand-picked herb grows naturally in mountains and contains triterpene glycosides (Ginsenosides, <xref ref-type="fig" rid="F4">Figure 4</xref>) responsible for main pharmacological activities (<xref rid="B145" ref-type="bibr">145</xref>).&#x000a0;</p><p>Aqueous extract of <italic>ginseng</italic> with polyphenol contents exhibits anti-oxidant activity (<xref rid="B146" ref-type="bibr">146</xref>). The herbal medicine scavenges free radicals such as superoxide anions and hydroxyl radicals and enhances the activity of the SOD enzyme (<xref rid="B147" ref-type="bibr">147</xref>).&#x000a0;</p><p>Choi <italic>et al.</italic> demonstrated that <italic>ginseng</italic> extract inhibits neuronal death and neuro-inflammation. With inhibition of hyperphosphorylation of tau protein, <italic>ginseng</italic> prevents formation of the neurofibrillary tangle. Further, it is able to inhibit the BACE1 enzyme and, therefore, reduce the level of A&#x003b2; (<xref rid="B148" ref-type="bibr">148</xref>). Ginsenosides increase hippocampal expression of brain-derived nerve factor (BDNF) (<xref rid="B149" ref-type="bibr">149</xref>), a key neuromodulator in learning and memory processing. Consistently, biochemical and behavioral evaluations have demonstrated that <italic>ginseng</italic> can improve stress-induced learning and memory impairment (<xref rid="B150" ref-type="bibr">150</xref>-<xref rid="B152" ref-type="bibr">152</xref>). Hence, it is proposed that the phytomedicine can play a distinct positive role in attenuation of memory impairment in AD (<xref rid="B148" ref-type="bibr">148</xref>).&#x000a0;&#x000a0;</p><p>It has been reported that ginsenoside inhibits activity of AChE and BchE in cultured PC12 cell line resulting in increased amount of ACh content (<xref rid="B153" ref-type="bibr">153</xref>). In parallel, it restores choline acetyltransferase activity in an animal model of AD (<xref rid="B154" ref-type="bibr">154</xref>). It also shows neuroprotective ability where it suppresses the glutamate-induced toxicity in AD (<xref rid="B155" ref-type="bibr">155</xref>, <xref rid="B156" ref-type="bibr">156</xref>).&#x000a0;</p><p>
<italic>In vivo and in vitro</italic> studies have indicated that <italic>ginseng</italic> has anti-inflammatory activity through attenuating expression of inflammatory mediators such as TNF&#x003b1;, NF-&#x003ba;B, IL1&#x003b2;, and IL6 (<xref rid="B157" ref-type="bibr">157</xref>-<xref rid="B159" ref-type="bibr">159</xref>). It also decreases the level of the COX-2 enzyme, a key mediator in the inflammatory process (<xref rid="B160" ref-type="bibr">160</xref>).&#x000a0;&#x000a0;</p><p>
<bold><italic>Salvia miltiorrhiza&#x000a0;</italic></bold>
</p><p>
<italic>Salvia miltiorrhiza</italic> is another member of <italic>the Lamiaceae</italic> family with branching stems and widely spaced leaves. It has been broadly used for treatment of various&#x000a0;diseases (<xref rid="B162" ref-type="bibr">162</xref>-<xref rid="B164" ref-type="bibr">164</xref>).&#x000a0;</p><p>Cryptotanshinone (<xref ref-type="fig" rid="F5">Figure 5</xref>), as the main active ingredient of <italic>S. miltiorrhiza</italic>, possesses many pharmaceutical functions including anti-AChE (<xref rid="B165" ref-type="bibr">165</xref>), anti-neurotoxicity (<xref rid="B166" ref-type="bibr">166</xref>), anti-inflammatory (<xref rid="B167" ref-type="bibr">167</xref>), anti-oxidative (<xref rid="B168" ref-type="bibr">168</xref>), and anti-apoptotic activities (<xref rid="B169" ref-type="bibr">169</xref>). Cryptotanshinone is reported to reduce A&#x003b2; deposition and improve spatial learning impairment (<xref rid="B170" ref-type="bibr">170</xref>). By affecting the gamma-secretase pathway, it prevents A&#x003b2; plaque formation and inhibits glutamate-induced neuronal toxicity (<xref rid="B166" ref-type="bibr">166</xref>). It is reported that cryptotanshinone ameliorates cognitive disturbance and significantly affect amnesia (<xref rid="B165" ref-type="bibr">165</xref>).&#x000a0;</p><p>Salvianolic acid is another polyphenolic derivative of <italic>S. miltiorrhiza</italic> that displays anti-inflammatory and anti-oxidant activity (<xref rid="B171" ref-type="bibr">171</xref>) and influences AD symptoms (<xref rid="B172" ref-type="bibr">172</xref>, <xref rid="B173" ref-type="bibr">173</xref>). It dose-dependently prevents self-aggregation of A&#x003b2; and further disaggregates A&#x003b2; fibrils and protects cells against A&#x003b2; fibrils neurotoxic effect (<xref rid="B174" ref-type="bibr">174</xref>).&#x000a0;Zhang <italic>et al.</italic> demonstrated that salvianolic acid increases BDNF expression and stimulates neuronal differentiation (<xref rid="B175" ref-type="bibr">175</xref>). Salvianolic acid protects the PC12 cell line against neurotoxicity induced by H<sub>2</sub>O<sub>2</sub> and reduces lipid peroxidation and perseveres anti-oxidant enzymes, intracellular ca2+ level, and caspase-3 enzyme in the normal activity state (<xref rid="B176" ref-type="bibr">176</xref>). Zhang <italic>et al.</italic> demonstrated that salvianolic acid decreases leakage of lactate dehydrogenase and, hence, protects neuronal cells against H<sub>2</sub>O<sub>2</sub> damage (<xref rid="B177" ref-type="bibr">177</xref>).&#x000a0;</p><p>Another constituent of <italic>S. miltiorrhiza</italic>, tanshinone, displays anti-oxidant activity. It can chelate metal ions that stimulate A&#x003b2; plaque formation and also inhibits ROS formation (<xref rid="B178" ref-type="bibr">178</xref>, <xref rid="B179" ref-type="bibr">179</xref>). Tanshinone suppresses expression of <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pubmed/15914026">inducible nitric oxide synthase </ext-link>(iNOS) and NO, and inhibits expression of inflammatory mediators (<xref rid="B167" ref-type="bibr">167</xref>, <xref rid="B180" ref-type="bibr">180</xref>).&#x000a0;&#x000a0;</p><p>It is reported that tanshinone has a strong preventive activity on the AChE enzyme (<xref rid="B165" ref-type="bibr">165</xref>) and significantly improves the amnesic activity in behavioral examination (<xref rid="B181" ref-type="bibr">181</xref>). Moreover, a study showed that tanshinone restores learning and memory deficit induced by scopolamine (<xref rid="B182" ref-type="bibr">182</xref>). Anti-apoptotic activity of tanshinone is shown to be due to down-regulation of caspase-3 expression or up-regulation of Bcl-2 expression (<xref rid="B183" ref-type="bibr">183</xref>). Tanshinone can activate the Bcl-xL pathway and, thus, through that, suppresses A&#x003b2; induced apoptosis (<xref rid="B184" ref-type="bibr">184</xref>).&#x000a0;</p><p>
<bold><italic>Magnolia officinalis</italic></bold>
</p><p>
<italic>Magnolia officinalis</italic> is a deciduous tree with thick and brown aromatic bark and fragrant flowers used as a rich source of biologically active compounds (<xref rid="B186" ref-type="bibr">186</xref>). This curative herb displays some medicinal aspects including anti-inflammatory (<xref rid="B187" ref-type="bibr">187</xref>), anti-oxidative (<xref rid="B188" ref-type="bibr">188</xref>), and neuroprotective activities (<xref rid="B189" ref-type="bibr">189</xref>). <italic>M. officinalis</italic> reduces the expression of inflammatory agents especially those stimulating NOS and inhibits activation of astrocytes and microglia (<xref rid="B190" ref-type="bibr">190</xref>). The multifunctional activity of <italic>M. officinalis</italic> is due to some ingredients such as magnolol (<xref ref-type="fig" rid="F6">Figure 6</xref>), 4-O-methylhonokiol, honokiol, obovatol, and magnolol (<xref rid="B191" ref-type="bibr">191</xref>-<xref rid="B193" ref-type="bibr">193</xref>). It is reported that magnolia, as a major bioactive component of <italic>M. officinalis</italic>, positively impacts different oxidative agents and inflammatory cytokines, including ROS, iNOS, NF-&#x003ba;B, TNF-&#x003b1;, TGF-&#x003b2;, IL-1&#x003b2;, COX2, and MAP kinases family (<xref rid="B191" ref-type="bibr">191</xref>). It also up-regulates some proteins effective in anti-inflammatory activities such as Ras and Raf proteins (<xref rid="B194" ref-type="bibr">194</xref>).&#x000a0;Honokiol, magnolol and 4-O-methylhonokiol display some neuroprotective effects through prevention of A&#x003b2; induced cell death, reduction of ROS generation, suppression of intracellular calcium elevation, and inhibition of caspase-3 activity (<xref rid="B190" ref-type="bibr">190</xref>, <xref rid="B195" ref-type="bibr">195</xref>).</p><p>It is shown that the ethanol extract of <italic>M. officinalis</italic> has a preventive effect on A&#x003b2; accumulation in the mouse brain (<xref rid="B196" ref-type="bibr">196</xref>). It also inhibits the expression of BACE1 and therefore prevents A&#x003b2; production and has a hampering effect on memorial perturbation induced by A&#x003b2; plaque (<xref rid="B196" ref-type="bibr">196</xref>, <xref rid="B197" ref-type="bibr">197</xref>). It was shown that 4-O-methylhonokiol prevents apoptosis induced by A&#x003b2;, resulting in cell survival, and down-regulates &#x003b2;-secretase expression and, thus, prevents A&#x003b2; formation. It also inhibits ROS generation and plays inhibitory action on H<sub>2</sub>O<sub>2</sub> induced neurotoxicity (<xref rid="B198" ref-type="bibr">198</xref>, <xref rid="B199" ref-type="bibr">199</xref>). Magnolol and honokiol inhibit AChE activity and stimulate release of ACh in the brain particularly in the hippocampus (<xref rid="B200" ref-type="bibr">200</xref>, <xref rid="B201" ref-type="bibr">201</xref>).</p><p>It is documented that the ethanol extract of <italic>M. officinalis</italic> prevents memory deficit in an animal model of AD (<xref rid="B190" ref-type="bibr">190</xref>). Evidence indicates that ethanol extract of this medicinal herb reduces the level and activity of AChE in the cortex and hippocampus of mice treated with scopolamine (<xref rid="B192" ref-type="bibr">192</xref>). Table 1 summarizes the biochemical, histopathological, and behavioral effects of the herbal medicines in <italic>in vivo</italic> and <italic>in vitro</italic> studies.</p><fig id="F1" position="float"><label>Figure 1</label><caption><p>Chemical structure of caffeic acid, luteolin, linalool, and linalyl acetate (<xref rid="B77" ref-type="bibr">77</xref>, <xref rid="B85" ref-type="bibr">85</xref>)</p></caption><graphic xlink:href="IJBMS-24-123-g001"/></fig><fig id="F2" position="float"><label>Figure 2</label><caption><p>Chemical structure of ginkgolide (<xref rid="B109" ref-type="bibr">109</xref>)</p></caption><graphic xlink:href="IJBMS-24-123-g002"/></fig><fig id="F3" position="float"><label>Figure 3</label><caption><p>Chemical structure of crocin (<xref rid="B131" ref-type="bibr">131</xref>)</p></caption><graphic xlink:href="IJBMS-24-123-g003"/></fig><fig id="F4" position="float"><label>Figure 4</label><caption><p>Chemical structure of ginsenosides (<xref rid="B161" ref-type="bibr">161</xref>)</p></caption><graphic xlink:href="IJBMS-24-123-g004"/></fig><fig id="F5" position="float"><label>Figure 5</label><caption><p>Chemical structure of Cryptotanshinone (<xref rid="B185" ref-type="bibr">185</xref>)</p></caption><graphic xlink:href="IJBMS-24-123-g005"/></fig><fig id="F6" position="float"><label>Figure 6</label><caption><p>Chemical structure of magnolol (<xref rid="B202" ref-type="bibr">202</xref>)</p></caption><graphic xlink:href="IJBMS-24-123-g006"/></fig></sec><sec sec-type="conclusions"><title>Conclusion</title><p>Taken together, extracellular A&#x003b2; plaque formation and intracellular accumulation of NFT are the main pathological features of AD. These structural abnormalities lead finally to neuronal death and synaptic loss which, in turn, result in violent neurobehavioral damages, mainly recent memory impairments. Oxidative agents, inflammatory factors, glutamate, or A&#x003b2; induced neurotoxicity, and cholinergic transmission deficit also promote occurrence of the diseases. Anti-oxidative, anti-inflammatory, and anti-neurotoxicity properties, as well as A&#x003b2; formation inhibitory and cholinergic excitatory activities of the herbal medicines are promising for the prevention and treatment of AD. As reviewed in this paper numerous herbal plants have potential therapeutic effects on AD associated symptoms. Despite abundant preclinical studies on the effectiveness of medicinal plants for neurodegenerative diseases including AD, clinical research is also required to warrant the use of herbal medicine in alleviating AD symptoms.&#x000a0;&#x000a0;</p></sec></body><back><ack><title>Acknowledgment</title><p>This review paper was supported by grant No. 97132 from Deputy of Research, Kashan University of Medical Sciences, Kashan, Iran to M Salami.&#x000a0;&#x000a0;&#x000a0;</p></ack><sec><title>Coflicts of Interest</title><p>The authors declare that there are no conflicts of interest.</p></sec><ref-list><title>References</title><ref id="B1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soheili</surname><given-names>M</given-names></name><name><surname>Tavirani</surname><given-names>MR</given-names></name><name><surname>Salami</surname><given-names>M</given-names></name></person-group><article-title>Lavandula angustifolia extract improves deteriorated synaptic plasticity in an animal model of Alzheimer&#x02019;s disease</article-title><source> Iran J Basic Med Sci</source><year>2015</year><volume>18</volume><fpage>1147</fpage><lpage>1152</lpage><pub-id pub-id-type="pmid">26949505</pub-id></element-citation></ref><ref id="B2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salami</surname><given-names>M</given-names></name><name><surname>Alinaghipour</surname><given-names>A</given-names></name><name><surname>Daneshvar</surname><given-names>R</given-names></name><name><surname>Hamidi</surname><given-names>GA</given-names></name><name><surname>Agahi</surname><given-names>A</given-names></name><name><surname>Soheili</surname><given-names>M</given-names></name><etal/></person-group><article-title>Adapted MMSE and TYM cognitive tests: how much powerful in screening for Alzheimer&#x02019;s disease in Iranian people</article-title><source> Aging Ment Health</source><year>2020</year><volume>24</volume><fpage>1010</fpage><lpage>1017</lpage><pub-id pub-id-type="pmid">30884962</pub-id></element-citation></ref><ref id="B3"><label>3</label><element-citation publication-type="book"><collab>World Health Organization</collab><source>Neurological disorders: public health challenges</source><year>2006</year><publisher-name>Switzerland: World Health Organization</publisher-name><fpage>204</fpage><lpage>207</lpage></element-citation></ref><ref id="B4"><label>4</label><element-citation publication-type="webpage"><collab>Alzheimer&#x02019;s Disease International</collab><source>World Alzheimer Report 2016, Improving healthcare for people living with dementia: Coverage, quality and costs now and in the future</source><comment>available at: <ext-link ext-link-type="uri" xlink:href="https://www.alz.co.uk/research/world-report-2016">https://www.alz.co.uk/research/world-report-2016</ext-link></comment></element-citation></ref><ref id="B5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kashani</surname><given-names>MS</given-names></name><name><surname>Tavirani</surname><given-names>MR</given-names></name><name><surname>Talaei</surname><given-names>SA</given-names></name><name><surname>Salami</surname><given-names>M</given-names></name></person-group><article-title>Aqueous extract of lavender (Lavandula angustifolia) improves the spatial performance of a rat model of Alzheimer&#x02019;s disease</article-title><source> Neurosci Bull</source><year>2011</year><fpage>27:99</fpage><lpage>106</lpage></element-citation></ref><ref id="B6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blaisdell</surname><given-names>AP</given-names></name></person-group><article-title>Mental imagery in animals: Learning, memory, and decision-making in the face of missing information</article-title><source> Learn Behav</source><year>2019</year><volume>47</volume><fpage>193</fpage><lpage>216</lpage><pub-id pub-id-type="pmid">31228005</pub-id></element-citation></ref><ref id="B7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ritvo</surname><given-names>VJH</given-names></name><name><surname>Turk-Browne</surname><given-names>NB</given-names></name><name><surname>Norman</surname><given-names>KA</given-names></name></person-group><article-title>Nonmonotonic plasticity: How memory retrieval drives learning</article-title><source> Trends Cogn Sci</source><year>2019</year><volume>23</volume><fpage>726</fpage><lpage>742</lpage><pub-id pub-id-type="pmid">31358438</pub-id></element-citation></ref><ref id="B8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rowland</surname><given-names>HA</given-names></name><name><surname>Hooper</surname><given-names>NM</given-names></name><name><surname>Kellett</surname><given-names>KAB</given-names></name></person-group><article-title>Modelling sporadic Alzheimer&#x02019;s disease using induced pluripotent stem cells</article-title><source> Neurochem Res</source><year>2018</year><volume>43</volume><fpage>2179</fpage><lpage>2198</lpage><pub-id pub-id-type="pmid">30387070</pub-id></element-citation></ref><ref id="B9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Israel</surname><given-names>MA</given-names></name><name><surname>Yuan</surname><given-names>SH</given-names></name><name><surname>Bardy</surname><given-names>C</given-names></name><name><surname>Reyna</surname><given-names>SM</given-names></name><name><surname>Mu</surname><given-names>Y</given-names></name><name><surname>Herrera</surname><given-names>C</given-names></name><etal/></person-group><article-title>Probing sporadic and familial Alzheimer&#x02019;s disease using induced pluripotent stem cells</article-title><source> Nature</source><year>2012</year><volume>482</volume><fpage>216</fpage><lpage>220</lpage><pub-id pub-id-type="pmid">22278060</pub-id></element-citation></ref><ref id="B10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kondo</surname><given-names>T</given-names></name><name><surname>Asai</surname><given-names>M</given-names></name><name><surname>Tsukita</surname><given-names>K</given-names></name><name><surname>Kutoku</surname><given-names>Y</given-names></name><name><surname>Ohsawa</surname><given-names>Y</given-names></name><name><surname>Sunada</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Modeling Alzheimer&#x02019;s disease with iPSCs reveals stress phenotypes associated with intracellular Abeta and differential drug responsiveness</article-title><source> Cell Stem Cell</source><year>2013</year><volume>12</volume><fpage>487</fpage><lpage>496</lpage><pub-id pub-id-type="pmid">23434393</pub-id></element-citation></ref><ref id="B11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mulder</surname><given-names>SD</given-names></name><name><surname>Nielsen</surname><given-names>HM</given-names></name><name><surname>Blankenstein</surname><given-names>MA</given-names></name><name><surname>Eikelenboom</surname><given-names>P</given-names></name><name><surname>Veerhuis</surname><given-names>R</given-names></name></person-group><article-title>Apolipoproteins E and J interfere with amyloid-beta uptake by primary human astrocytes and microglia in vitro</article-title><source> Glia</source><year>2014</year><volume>62</volume><fpage>493</fpage><lpage>503</lpage><pub-id pub-id-type="pmid">24446231</pub-id></element-citation></ref><ref id="B12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Howes</surname><given-names>MJ</given-names></name><name><surname>Houghton</surname><given-names>PJ</given-names></name></person-group><article-title>Ethnobotanical treatment strategies against Alzheimer&#x02019;s disease</article-title><source> Curr Alzheimer Res</source><year>2012</year><volume>9</volume><fpage>67</fpage><lpage>85</lpage><pub-id pub-id-type="pmid">22329652</pub-id></element-citation></ref><ref id="B13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheignon</surname><given-names>C</given-names></name><name><surname>Tomas</surname><given-names>M</given-names></name><name><surname>Bonnefont-Rousselot</surname><given-names>D</given-names></name><name><surname>Faller</surname><given-names>P</given-names></name><name><surname>Hureau</surname><given-names>C</given-names></name><name><surname>Collin</surname><given-names>F</given-names></name></person-group><article-title>Oxidative stress and the amyloid beta peptide in Alzheimer&#x02019;s disease</article-title><source> Redox Biol</source><year>2018</year><volume>14</volume><fpage>450</fpage><lpage>464</lpage><pub-id pub-id-type="pmid">29080524</pub-id></element-citation></ref><ref id="B14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Westergard</surname><given-names>L</given-names></name><name><surname>Christensen</surname><given-names>HM</given-names></name><name><surname>Harris</surname><given-names>DA</given-names></name></person-group><article-title>The cellular prion protein (PrP(C)): its physiological function and role in disease</article-title><source> Biochim Biophys Acta</source><year>2007</year><volume>1772</volume><fpage>629</fpage><lpage>644</lpage><pub-id pub-id-type="pmid">17451912</pub-id></element-citation></ref><ref id="B15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Latta</surname><given-names>CH</given-names></name><name><surname>Brothers</surname><given-names>HM</given-names></name><name><surname>Wilcock</surname><given-names>DM</given-names></name></person-group><article-title>Neuroinflammation in Alzheimer&#x02019;s disease; A source of heterogeneity and target for personalized therapy</article-title><source> Neuroscience</source><year>2015</year><volume>302</volume><fpage>103</fpage><lpage>111</lpage><pub-id pub-id-type="pmid">25286385</pub-id></element-citation></ref><ref id="B16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Akhondzadeh</surname><given-names>S</given-names></name><name><surname>Abbasi</surname><given-names>SH</given-names></name></person-group><article-title>Herbal medicine in the treatment of Alzheimer&#x02019;s disease</article-title><source> Am J Alzheimers Dis Other Demen</source><year>2006</year><volume>21</volume><fpage>113</fpage><lpage>118</lpage><pub-id pub-id-type="pmid">16634467</pub-id></element-citation></ref><ref id="B17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shi</surname><given-names>J</given-names></name><name><surname>Ni</surname><given-names>J</given-names></name><name><surname>Lu</surname><given-names>T</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Wei</surname><given-names>M</given-names></name><name><surname>Li</surname><given-names>T</given-names></name><etal/></person-group><article-title>Adding Chinese herbal medicine to conventional therapy brings cognitive benefits to patients with Alzheimer&#x02019;s disease: a retrospective analysis</article-title><source> BMC Complement Altern Med</source><year>2017</year><volume>17</volume><fpage>533</fpage><lpage>539</lpage><pub-id pub-id-type="pmid">29237450</pub-id></element-citation></ref><ref id="B18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>JG</given-names></name><name><surname>Wang</surname><given-names>YY</given-names></name><name><surname>Zhang</surname><given-names>ZL</given-names></name><name><surname>Yu</surname><given-names>B</given-names></name></person-group><article-title>Herbal medicine in the treatment of Alzheimer&#x02019;s disease</article-title><source> Chin J Integr Med</source><year>2015</year><volume>21</volume><fpage>102</fpage><lpage>107</lpage><pub-id pub-id-type="pmid">24752473</pub-id></element-citation></ref><ref id="B19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mawuenyega</surname><given-names>KG</given-names></name><name><surname>Sigurdson</surname><given-names>W</given-names></name><name><surname>Ovod</surname><given-names>V</given-names></name><name><surname>Munsell</surname><given-names>L</given-names></name><name><surname>Kasten</surname><given-names>T</given-names></name><name><surname>Morris</surname><given-names>JC</given-names></name><etal/></person-group><article-title>Decreased clearance of CNS beta-amyloid in Alzheimer&#x02019;s disease</article-title><source> Science</source><year>2010</year><volume>330</volume><fpage>1774</fpage><lpage>1777</lpage><pub-id pub-id-type="pmid">21148344</pub-id></element-citation></ref><ref id="B20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Steiner</surname><given-names>H</given-names></name><name><surname>Fukumori</surname><given-names>A</given-names></name><name><surname>Tagami</surname><given-names>S</given-names></name><name><surname>Okochi</surname><given-names>M</given-names></name></person-group><article-title>Making the final cut: pathogenic amyloid-beta peptide generation by gamma-secretase</article-title><source> Cell Stress</source><year>2018</year><volume>2</volume><fpage>292</fpage><lpage>310</lpage><pub-id pub-id-type="pmid">31225454</pub-id></element-citation></ref><ref id="B21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bergstrom</surname><given-names>P</given-names></name><name><surname>Agholme</surname><given-names>L</given-names></name><name><surname>Nazir</surname><given-names>FH</given-names></name><name><surname>Satir</surname><given-names>TM</given-names></name><name><surname>Toombs</surname><given-names>J</given-names></name><name><surname>Wellington</surname><given-names>H</given-names></name><etal/></person-group><article-title>Amyloid precursor protein expression and processing are differentially regulated during cortical neuron differentiation</article-title><source> Sci Rep</source><year>2016</year><volume>6</volume><fpage>29200</fpage><lpage>29213</lpage><pub-id pub-id-type="pmid">27383650</pub-id></element-citation></ref><ref id="B22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sato</surname><given-names>N</given-names></name><name><surname>Morishita</surname><given-names>R</given-names></name></person-group><article-title>The roles of lipid and glucose metabolism in modulation of beta-amyloid, tau, and neurodegeneration in the pathogenesis of Alzheimer disease</article-title><source> Front Aging Neurosci</source><year>2015</year><volume>7</volume><fpage>199</fpage><lpage>207</lpage><pub-id pub-id-type="pmid">26557086</pub-id></element-citation></ref><ref id="B23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arbel-Ornath</surname><given-names>M</given-names></name><name><surname>Hudry</surname><given-names>E</given-names></name><name><surname>Eikermann-Haerter</surname><given-names>K</given-names></name><name><surname>Hou</surname><given-names>S</given-names></name><name><surname>Gregory</surname><given-names>JL</given-names></name><name><surname>Zhao</surname><given-names>L</given-names></name><etal/></person-group><article-title>Interstitial fluid drainage is impaired in ischemic stroke and Alzheimer&#x02019;s disease mouse models</article-title><source> Acta Neuropathol</source><year>2013</year><volume>126</volume><fpage>353</fpage><lpage>364</lpage><pub-id pub-id-type="pmid">23818064</pub-id></element-citation></ref><ref id="B24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saido</surname><given-names>T</given-names></name><name><surname>Leissring</surname><given-names>MA</given-names></name></person-group><article-title>Proteolytic degradation of amyloid beta-protein</article-title><source> Cold Spring Harb Perspect Med</source><year>2012</year><volume>2</volume><fpage>1</fpage><lpage>18</lpage></element-citation></ref><ref id="B25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Metaxas</surname><given-names>A</given-names></name><name><surname>Kempf</surname><given-names>SJ</given-names></name></person-group><article-title>Neurofibrillary tangles in Alzheimer&#x02019;s disease: elucidation of the molecular mechanism by immunohistochemistry and tau protein phospho-proteomics</article-title><source> Neural Regen Res</source><year>2016</year><volume>11</volume><fpage>1579</fpage><lpage>1581</lpage><pub-id pub-id-type="pmid">27904486</pub-id></element-citation></ref><ref id="B26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lasagna-Reeves</surname><given-names>CA</given-names></name><name><surname>Castillo-Carranza</surname><given-names>DL</given-names></name><name><surname>Sengupta</surname><given-names>U</given-names></name><name><surname>Sarmiento</surname><given-names>J</given-names></name><name><surname>Troncoso</surname><given-names>J</given-names></name><name><surname>Jackson</surname><given-names>GR</given-names></name><etal/></person-group><article-title>Identification of oligomers at early stages of tau aggregation in Alzheimer&#x02019;s disease</article-title><source> Faseb j</source><year>2012</year><volume>26</volume><fpage>1946</fpage><lpage>1959</lpage><pub-id pub-id-type="pmid">22253473</pub-id></element-citation></ref><ref id="B27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stancu</surname><given-names>IC</given-names></name><name><surname>Vasconcelos</surname><given-names>B</given-names></name><name><surname>Terwel</surname><given-names>D</given-names></name><name><surname>Dewachter</surname><given-names>I</given-names></name></person-group><article-title>Models of beta-amyloid induced Tau-pathology: the long and &#x0201c;folded&#x0201d; road to understand the mechanism</article-title><source> Mol Neurodegener</source><year>2014</year><volume>9</volume><fpage>51</fpage><lpage>64</lpage><pub-id pub-id-type="pmid">25407337</pub-id></element-citation></ref><ref id="B28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spillantini</surname><given-names>MG</given-names></name><name><surname>Murrell</surname><given-names>JR</given-names></name><name><surname>Goedert</surname><given-names>M</given-names></name><name><surname>Farlow</surname><given-names>MR</given-names></name><name><surname>Klug</surname><given-names>A</given-names></name><name><surname>Ghetti</surname><given-names>B</given-names></name></person-group><article-title>Mutation in the tau gene in familial multiple system tauopathy with presenile dementia</article-title><source> Proc Natl Acad Sci U S A</source><year>1998</year><volume>95</volume><fpage>7737</fpage><lpage>7741</lpage><pub-id pub-id-type="pmid">9636220</pub-id></element-citation></ref><ref id="B29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>F</given-names></name><name><surname>Tsien</surname><given-names>JZ</given-names></name></person-group><article-title>Memory and the NMDA receptors</article-title><source> The N Eng J Med</source><year>2009</year><volume>361</volume><fpage>302</fpage><lpage>303</lpage></element-citation></ref><ref id="B30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rapp</surname><given-names>A</given-names></name><name><surname>Gmeiner</surname><given-names>B</given-names></name><name><surname>Huttinger</surname><given-names>M</given-names></name></person-group><article-title>Implication of apoE isoforms in cholesterol metabolism by primary rat hippocampal neurons and astrocytes</article-title><source> Biochimie</source><year>2006</year><volume>88</volume><fpage>473</fpage><lpage>483</lpage><pub-id pub-id-type="pmid">16376010</pub-id></element-citation></ref><ref id="B31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Snyder</surname><given-names>EM</given-names></name><name><surname>Nong</surname><given-names>Y</given-names></name><name><surname>Almeida</surname><given-names>CG</given-names></name><name><surname>Paul</surname><given-names>S</given-names></name><name><surname>Moran</surname><given-names>T</given-names></name><name><surname>Choi</surname><given-names>EY</given-names></name><etal/></person-group><article-title>Regulation of NMDA receptor trafficking by amyloid-beta</article-title><source> Nat Neurosci</source><year>2005</year><volume>8</volume><fpage>1051</fpage><lpage>1058</lpage><pub-id pub-id-type="pmid">16025111</pub-id></element-citation></ref><ref id="B32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dzamba</surname><given-names>D</given-names></name><name><surname>Harantova</surname><given-names>L</given-names></name><name><surname>Butenko</surname><given-names>O</given-names></name><name><surname>Anderova</surname><given-names>M</given-names></name></person-group><article-title>Glial cells - The key elements of Alzheimer s Disease</article-title><source> Curr Alzheimer Res</source><year>2016</year><volume>13</volume><fpage>894</fpage><lpage>911</lpage><pub-id pub-id-type="pmid">26825092</pub-id></element-citation></ref><ref id="B33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seixas</surname><given-names>da Silva GS</given-names></name><name><surname>Melo</surname><given-names>HM</given-names></name><name><surname>Lourenco</surname><given-names>MV</given-names></name><name><surname>Lyra</surname><given-names>ESNM</given-names></name><name><surname>de</surname><given-names>Carvalho MB</given-names></name><name><surname>Alves-Leon</surname><given-names>SV</given-names></name><etal/></person-group><article-title>Amyloid-beta oligomers transiently inhibit AMP-activated kinase and cause metabolic defects in hippocampal neurons</article-title><source> J Biol Chem</source><year>2017</year><volume>292</volume><fpage>7395</fpage><lpage>7406</lpage><pub-id pub-id-type="pmid">28302722</pub-id></element-citation></ref><ref id="B34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buttini</surname><given-names>M</given-names></name><name><surname>Masliah</surname><given-names>E</given-names></name><name><surname>Yu</surname><given-names>GQ</given-names></name><name><surname>Palop</surname><given-names>JJ</given-names></name><name><surname>Chang</surname><given-names>S</given-names></name><name><surname>Bernardo</surname><given-names>A</given-names></name><etal/></person-group><article-title>Cellular source of apolipoprotein E4 determines neuronal susceptibility to excitotoxic injury in transgenic mice</article-title><source> Am J Pathol</source><year>2010</year><volume>177</volume><fpage>563</fpage><lpage>569</lpage><pub-id pub-id-type="pmid">20595630</pub-id></element-citation></ref><ref id="B35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kandemirli</surname><given-names>F</given-names></name><name><surname>Saracoglu</surname><given-names>M</given-names></name><name><surname>Kovalishyn</surname><given-names>V</given-names></name></person-group><article-title>Human acetylcholinesterase inhibitors: electronic-topological and neural network approaches to the structure-activity relationships study</article-title><source> Mini Rev Med Chem</source><year>2005</year><volume>5</volume><fpage>479</fpage><lpage>487</lpage><pub-id pub-id-type="pmid">15892689</pub-id></element-citation></ref><ref id="B36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Day</surname><given-names>T</given-names></name><name><surname>Greenfield</surname><given-names>SA</given-names></name></person-group><article-title>A non-cholinergic, trophic action of acetylcholinesterase on hippocampal neurones in vitro: molecular mechanisms</article-title><source> Neuroscience</source><year>2002</year><volume>111</volume><fpage>649</fpage><lpage>656</lpage><pub-id pub-id-type="pmid">12031351</pub-id></element-citation></ref><ref id="B37"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mufson</surname><given-names>EJ</given-names></name><name><surname>Ginsberg</surname><given-names>SD</given-names></name><name><surname>Ikonomovic</surname><given-names>MD</given-names></name><name><surname>DeKosky</surname><given-names>ST</given-names></name></person-group><article-title>Human cholinergic basal forebrain: chemoanatomy and neurologic dysfunction</article-title><source> J Chem Neuroanat</source><year>2003</year><volume>26</volume><fpage>233</fpage><lpage>242</lpage><pub-id pub-id-type="pmid">14729126</pub-id></element-citation></ref><ref id="B38"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pacheco</surname><given-names>G</given-names></name><name><surname>Palacios-Esquivel</surname><given-names>R</given-names></name><name><surname>Moss</surname><given-names>DE</given-names></name></person-group><article-title>Cholinesterase inhibitors proposed for treating dementia in Alzheimer&#x02019;s disease: selectivity toward human brain acetylcholinesterase compared with butyrylcholinesterase</article-title><source> J Pharmacol Exp Ther</source><year>1995</year><volume>274</volume><fpage>767</fpage><lpage>770</lpage><pub-id pub-id-type="pmid">7636741</pub-id></element-citation></ref><ref id="B39"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reale</surname><given-names>M</given-names></name><name><surname>Di</surname><given-names>Nicola M</given-names></name><name><surname>Velluto</surname><given-names>L</given-names></name><name><surname>D&#x02019;Angelo</surname><given-names>C</given-names></name><name><surname>Costantini</surname><given-names>E</given-names></name><name><surname>Lahiri</surname><given-names>DK</given-names></name><etal/></person-group><article-title>Selective acetyl- and butyrylcholinesterase inhibitors reduce amyloid-beta ex vivo activation of peripheral chemo-cytokines from Alzheimer&#x02019;s disease subjects: exploring the cholinergic anti-inflammatory pathway</article-title><source> Curr Alzheimer Res</source><year>2014</year><volume>11</volume><fpage>608</fpage><lpage>622</lpage><pub-id pub-id-type="pmid">24359497</pub-id></element-citation></ref><ref id="B40"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Richter</surname><given-names>N</given-names></name><name><surname>Beckers</surname><given-names>N</given-names></name><name><surname>Onur</surname><given-names>OA</given-names></name><name><surname>Dietlein</surname><given-names>M</given-names></name><name><surname>Tittgemeyer</surname><given-names>M</given-names></name><name><surname>Kracht</surname><given-names>L</given-names></name><etal/></person-group><article-title>Effect of cholinergic treatment depends on cholinergic integrity in early Alzheimer&#x0203a;s disease</article-title><source> Brain</source><year>2018</year><volume>141</volume><fpage>903</fpage><lpage>915</lpage><pub-id pub-id-type="pmid">29309600</pub-id></element-citation></ref><ref id="B41"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ceylan</surname><given-names>H</given-names></name><name><surname>Budak</surname><given-names>H</given-names></name><name><surname>Kocpinar</surname><given-names>EF</given-names></name><name><surname>Baltaci</surname><given-names>NG</given-names></name><name><surname>Erdogan</surname><given-names>O</given-names></name></person-group><article-title>Examining the link between dose-dependent dietary iron intake and Alzheimer&#x02019;s disease through oxidative stress in the rat cortex</article-title><source> J Trace Elem Med Biol</source><year>2019</year><volume>56</volume><fpage>198</fpage><lpage>206</lpage><pub-id pub-id-type="pmid">31525623</pub-id></element-citation></ref><ref id="B42"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakabeppu</surname><given-names>Y</given-names></name></person-group><article-title>Molecular pathophysiology of insulin depletion, mitochondrial dysfunction, and oxidative stress in Alzheimer&#x02019;s disease brain</article-title><source> Adv Exp Med Biol</source><year>2019</year><volume>1128</volume><fpage>27</fpage><lpage>44</lpage><pub-id pub-id-type="pmid">31062324</pub-id></element-citation></ref><ref id="B43"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roberts</surname><given-names>LJ</given-names></name><name><surname>Fessel</surname><given-names>JP</given-names></name></person-group><article-title>The biochemistry of the isoprostane, neuroprostane, and isofuran pathways of lipid eroxidation</article-title><source> Brain Pathol</source><year>2005</year><volume>15</volume><fpage>143</fpage><lpage>148</lpage><pub-id pub-id-type="pmid">15912887</pub-id></element-citation></ref><ref id="B44"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reed</surname><given-names>TT</given-names></name></person-group><article-title>Lipid peroxidation and neurodegenerative disease</article-title><source> Free Radic Biol Med</source><year>2011</year><volume>51</volume><fpage>1302</fpage><lpage>1319</lpage><pub-id pub-id-type="pmid">21782935</pub-id></element-citation></ref><ref id="B45"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cosin-Tomas</surname><given-names>M</given-names></name><name><surname>Senserrich</surname><given-names>J</given-names></name><name><surname>Arumi-Planas</surname><given-names>M</given-names></name><name><surname>Alquezar</surname><given-names>C</given-names></name><name><surname>Pallas</surname><given-names>M</given-names></name><name><surname>Martin-Requero</surname><given-names>A</given-names></name><etal/></person-group><article-title>Role of resveratrol and selenium on oxidative stress and expression of anti-oxidant and anti-aging genes in immortalized lymphocytes from Alzheimer&#x02019;s disease patients</article-title><source> Arch Toxicol</source><year>2019</year><volume>11</volume><fpage>1</fpage><lpage>23</lpage></element-citation></ref><ref id="B46"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Simunkova</surname><given-names>M</given-names></name><name><surname>Alwasel</surname><given-names>SH</given-names></name><name><surname>Alhazza</surname><given-names>IM</given-names></name><name><surname>Jomova</surname><given-names>K</given-names></name><name><surname>Kollar</surname><given-names>V</given-names></name><name><surname>Rusko</surname><given-names>M</given-names></name><etal/></person-group><article-title>Management of oxidative stress and other pathologies in Alzheimer&#x02019;s disease</article-title><source>Arch Toxicol</source><year>2019</year><volume>93</volume><fpage>2491</fpage><lpage>2513</lpage><pub-id pub-id-type="pmid">31440798</pub-id></element-citation></ref><ref id="B47"><label>47</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rosini</surname><given-names>M</given-names></name><name><surname>Simoni</surname><given-names>E</given-names></name><name><surname>Caporaso</surname><given-names>R</given-names></name><name><surname>Basagni</surname><given-names>F</given-names></name><name><surname>Catanzaro</surname><given-names>M</given-names></name><name><surname>Abu</surname><given-names>IF</given-names></name><etal/></person-group><article-title>Merging memantine and ferulic acid to probe connections between NMDA receptors, oxidative stress and amyloid-beta peptide in Alzheimer&#x02019;s disease</article-title><source> Eur J Med Chem</source><year>2019</year><volume>180</volume><fpage>111</fpage><lpage>120</lpage><pub-id pub-id-type="pmid">31301562</pub-id></element-citation></ref><ref id="B48"><label>48</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de</surname><given-names>la Monte SM</given-names></name><name><surname>Wands</surname><given-names>JR</given-names></name></person-group><article-title>Molecular indices of oxidative stress and mitochondrial dysfunction occur early and often progress with severity of Alzheimer&#x02019;s disease</article-title><source> J Alzheimers Dis</source><year>2006</year><volume>9</volume><fpage>167</fpage><lpage>181</lpage><pub-id pub-id-type="pmid">16873964</pub-id></element-citation></ref><ref id="B49"><label>49</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eckman</surname><given-names>J</given-names></name><name><surname>Dixit</surname><given-names>S</given-names></name><name><surname>Nackenoff</surname><given-names>A</given-names></name><name><surname>Schrag</surname><given-names>M</given-names></name><name><surname>Harrison</surname><given-names>FE</given-names></name></person-group><article-title>Oxidative stress levels in the brain are determined by postmortem interval and ante-mortem vitamin c state but not Alzheimer&#x02019;s disease Status</article-title><source> Nutrients</source><year>2018</year><volume>10</volume><fpage>1</fpage><lpage>11</lpage></element-citation></ref><ref id="B50"><label>50</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bueler</surname><given-names>H</given-names></name><name><surname>Fischer</surname><given-names>M</given-names></name><name><surname>Lang</surname><given-names>Y</given-names></name><name><surname>Bluethmann</surname><given-names>H</given-names></name><name><surname>Lipp</surname><given-names>HP</given-names></name><name><surname>DeArmond</surname><given-names>SJ</given-names></name><etal/></person-group><article-title>Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein</article-title><source> Nature</source><year>1992</year><volume>356</volume><fpage>577</fpage><lpage>582</lpage><pub-id pub-id-type="pmid">1373228</pub-id></element-citation></ref><ref id="B51"><label>51</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van</surname><given-names>Delft MF</given-names></name><name><surname>Huang</surname><given-names>DC</given-names></name></person-group><article-title>How the Bcl-2 family of proteins interact to regulate apoptosis</article-title><source> Cell Res</source><year>2006</year><volume>16</volume><fpage>203</fpage><lpage>213</lpage><pub-id pub-id-type="pmid">16474435</pub-id></element-citation></ref><ref id="B52"><label>52</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barry</surname><given-names>AE</given-names></name><name><surname>Klyubin</surname><given-names>I</given-names></name><name><surname>Mc</surname><given-names>Donald JM</given-names></name><name><surname>Mably</surname><given-names>AJ</given-names></name><name><surname>Farrell</surname><given-names>MA</given-names></name><name><surname>Scott</surname><given-names>M</given-names></name><etal/></person-group><article-title>Alzheimer&#x02019;s disease brain-derived amyloid-beta-mediated inhibition of LTP in vivo is prevented by immunotargeting cellular prion protein</article-title><source> J Neurosci</source><year>2011</year><volume>31</volume><fpage>7259</fpage><lpage>7263</lpage><pub-id pub-id-type="pmid">21593310</pub-id></element-citation></ref><ref id="B53"><label>53</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Whitehouse</surname><given-names>IJ</given-names></name><name><surname>Miners</surname><given-names>JS</given-names></name><name><surname>Glennon</surname><given-names>EB</given-names></name><name><surname>Kehoe</surname><given-names>PG</given-names></name><name><surname>Love</surname><given-names>S</given-names></name><name><surname>Kellett</surname><given-names>KA</given-names></name><etal/></person-group><article-title>Prion protein is decreased in Alzheimer&#x02019;s brain and inversely correlates with BACE1 activity, amyloid beta levels and Braak stage</article-title><source> PLoS One</source><year>2013</year><volume>8</volume><fpage>1</fpage><lpage>8</lpage></element-citation></ref><ref id="B54"><label>54</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kawahara</surname><given-names>M</given-names></name><name><surname>Kuroda</surname><given-names>Y</given-names></name><name><surname>Arispe</surname><given-names>N</given-names></name><name><surname>Rojas</surname><given-names>E</given-names></name></person-group><article-title>Alzheimer&#x02019;s beta-amyloid, human islet amylin, and prion protein fragment evoke intracellular free calcium elevations by a common mechanism in a hypothalamic GnRH neuronal cell line</article-title><source> J Biol Chem</source><year>2000</year><volume>275</volume><fpage>14077</fpage><lpage>14083</lpage><pub-id pub-id-type="pmid">10799482</pub-id></element-citation></ref><ref id="B55"><label>55</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O&#x02019;Banion</surname><given-names>MK</given-names></name></person-group><article-title>COX-2 and Alzheimer&#x02019;s disease: potential roles in inflammation and neurodegeneration</article-title><source> Expert Opin Investig Drugs</source><year>1999</year><volume>8</volume><fpage>1521</fpage><lpage>1536</lpage></element-citation></ref><ref id="B56"><label>56</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoozemans</surname><given-names>JJ</given-names></name><name><surname>van</surname><given-names>Haastert ES</given-names></name><name><surname>Veerhuis</surname><given-names>R</given-names></name><name><surname>Arendt</surname><given-names>T</given-names></name><name><surname>Scheper</surname><given-names>W</given-names></name><name><surname>Eikelenboom</surname><given-names>P</given-names></name><etal/></person-group><article-title>Maximal COX-2 and ppRb expression in neurons occurs during early Braak stages prior to the maximal activation of astrocytes and microglia in Alzheimer&#x02019;s disease</article-title><source> J Neuroinflammation</source><year>2005</year><volume>2</volume><fpage>1</fpage><lpage>57</lpage><pub-id pub-id-type="pmid">15642121</pub-id></element-citation></ref><ref id="B57"><label>57</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kimura</surname><given-names>M</given-names></name><name><surname>Asada</surname><given-names>T</given-names></name><name><surname>Uno</surname><given-names>M</given-names></name><name><surname>Machida</surname><given-names>N</given-names></name><name><surname>Kasuya</surname><given-names>K</given-names></name><name><surname>Taniguchi</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Assessment of cerebrospinal fluid levels of serum amyloid P component in patients with Alzheimer&#x02019;s disease</article-title><source> Neurosci Lett</source><year>1999</year><volume>273</volume><fpage>137</fpage><lpage>139</lpage><pub-id pub-id-type="pmid">10505635</pub-id></element-citation></ref><ref id="B58"><label>58</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Walker</surname><given-names>KA</given-names></name><name><surname>Ficek</surname><given-names>BN</given-names></name><name><surname>Westbrook</surname><given-names>R</given-names></name></person-group><article-title>Understanding the role of systemic inflammation in Alzheimer&#x02019;s disease</article-title><source> ACS Chem Neurosci</source><year>2019</year><volume>10</volume><fpage>3340</fpage><lpage>3342</lpage><pub-id pub-id-type="pmid">31241312</pub-id></element-citation></ref><ref id="B59"><label>59</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kolstoe</surname><given-names>SE</given-names></name><name><surname>Ridha</surname><given-names>BH</given-names></name><name><surname>Bellotti</surname><given-names>V</given-names></name><name><surname>Wang</surname><given-names>N</given-names></name><name><surname>Robinson</surname><given-names>CV</given-names></name><name><surname>Crutch</surname><given-names>SJ</given-names></name><etal/></person-group><article-title>Molecular dissection of Alzheimer&#x02019;s disease neuropathology by depletion of serum amyloid P component</article-title><source> Proc Natl Acad Sci U S A</source><year>2009</year><volume>106</volume><fpage>7619</fpage><lpage>7623</lpage><pub-id pub-id-type="pmid">19372378</pub-id></element-citation></ref><ref id="B60"><label>60</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Borisovskaya</surname><given-names>A</given-names></name><name><surname>Pascualy</surname><given-names>M</given-names></name><name><surname>Borson</surname><given-names>S</given-names></name></person-group><article-title>Cognitive and neuropsychiatric impairments in Alzheimer&#x02019;s disease: current treatment strategies</article-title><source> Curr Psychiatry Rep</source><year>2014</year><volume>16</volume><fpage>470</fpage><lpage>478</lpage><pub-id pub-id-type="pmid">25023513</pub-id></element-citation></ref><ref id="B61"><label>61</label><element-citation publication-type="journal"><article-title>Alzheimer&#x02019;s disease in France: too many patients exposed to drug interactions involving cholinesterase inhibitors</article-title><source>Prescrire Int</source><year>2014</year><volume>23</volume><fpage>150</fpage><lpage>156</lpage><pub-id pub-id-type="pmid">25121147</pub-id></element-citation></ref><ref id="B62"><label>62</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lipton</surname><given-names>SA</given-names></name></person-group><article-title>Paradigm shift in NMDA receptor antagonist drug development: molecular mechanism of uncompetitive inhibition by memantine in the treatment of Alzheimer&#x02019;s disease and other neurologic disorders</article-title><source> J Alzheimers Dis</source><year>2004</year><volume>6</volume><fpage>61</fpage><lpage>74</lpage></element-citation></ref><ref id="B63"><label>63</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Allison</surname><given-names>AC</given-names></name><name><surname>Cacabelos</surname><given-names>R</given-names></name><name><surname>Lombardi</surname><given-names>VR</given-names></name><name><surname>Alvarez</surname><given-names>XA</given-names></name><name><surname>Vigo</surname><given-names>C</given-names></name></person-group><article-title>Celastrol, a potent anti-oxidant and anti-inflammatory drug, as a possible treatment for Alzheimer&#x02019;s disease</article-title><source> Prog Neuropsychopharmacol Biol Psychiatry</source><year>2001</year><volume>25</volume><fpage>1341</fpage><lpage>1357</lpage><pub-id pub-id-type="pmid">11513350</pub-id></element-citation></ref><ref id="B64"><label>64</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cai</surname><given-names>R</given-names></name><name><surname>Wang</surname><given-names>LN</given-names></name><name><surname>Fan</surname><given-names>JJ</given-names></name><name><surname>Geng</surname><given-names>SQ</given-names></name><name><surname>Liu</surname><given-names>YM</given-names></name></person-group><article-title>New 4-N-phenylaminoquinoline derivatives as anti-oxidant, metal chelating and cholinesterase inhibitors for Alzheimer&#x02019;s disease</article-title><source> Bioorg Chem</source><year>2019</year><volume>93</volume><fpage>1</fpage><lpage>24</lpage></element-citation></ref><ref id="B65"><label>65</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Loera-Valencia</surname><given-names>R</given-names></name><name><surname>Cedazo-Minguez</surname><given-names>A</given-names></name><name><surname>Kenigsberg</surname><given-names>PA</given-names></name><name><surname>Page</surname><given-names>G</given-names></name><name><surname>Duarte</surname><given-names>AI</given-names></name><name><surname>Giusti</surname><given-names>P</given-names></name><etal/></person-group><article-title>Current and emerging avenues for Alzheimer&#x02019;s disease drug targets</article-title><source> J Int Med</source><year>2019</year><volume>286</volume><fpage>398</fpage><lpage>437</lpage></element-citation></ref><ref id="B66"><label>66</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kabir</surname><given-names>MT</given-names></name><name><surname>Uddin</surname><given-names>MS</given-names></name><name><surname>Begum</surname><given-names>MM</given-names></name><name><surname>Thangapandiyan</surname><given-names>S</given-names></name><name><surname>Rahman</surname><given-names>MS</given-names></name><name><surname>Aleya</surname><given-names>L</given-names></name><etal/></person-group><article-title>Cholinesterase inhibitors for Alzheimer disease: Multitargeting strategy based on anti- Alzheimer&#x02019;s drugs repositioning</article-title><source> Curr Pharm Des</source><year>2019</year><volume>25</volume><fpage>3519</fpage><lpage>3535</lpage><pub-id pub-id-type="pmid">31593530</pub-id></element-citation></ref><ref id="B67"><label>67</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kabir</surname><given-names>MT</given-names></name><name><surname>Abu</surname><given-names>Sufian M</given-names></name><name><surname>Uddin</surname><given-names>MS</given-names></name><name><surname>Begum</surname><given-names>MM</given-names></name><name><surname>Akhter</surname><given-names>S</given-names></name><name><surname>Islam</surname><given-names>A</given-names></name><etal/></person-group><article-title>NMDA receptor antagonists: Repositioning of memantine as multitargeting agent for Alzheimer&#x02019;s therapy</article-title><source> Curr Pharm Des</source><year>2019</year><volume>25</volume><fpage>3506</fpage><lpage>3518</lpage><pub-id pub-id-type="pmid">31604413</pub-id></element-citation></ref><ref id="B68"><label>68</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>SH</given-names></name><name><surname>Vlkolinsky</surname><given-names>R</given-names></name><name><surname>Cairns</surname><given-names>N</given-names></name><name><surname>Fountoulakis</surname><given-names>M</given-names></name><name><surname>Lubec</surname><given-names>G</given-names></name></person-group><article-title>The reduction of NADH ubiquinone oxidoreductase 24- and 75-kDa subunits in brains of patients with Down syndrome and Alzheimer&#x02019;s disease</article-title><source> Life Sci</source><year>2001</year><volume>68</volume><fpage>2741</fpage><lpage>2750</lpage><pub-id pub-id-type="pmid">11400916</pub-id></element-citation></ref><ref id="B69"><label>69</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mandal</surname><given-names>PK</given-names></name><name><surname>Shukla</surname><given-names>D</given-names></name><name><surname>Tripathi</surname><given-names>M</given-names></name><name><surname>Ersland</surname><given-names>L</given-names></name></person-group><article-title>Cognitive improvement with glutathione supplement in Alzheimer&#x02019;s disease: A way forward</article-title><source> J Alzheimers Dis</source><year>2019</year><volume>68</volume><fpage>531</fpage><lpage>535</lpage><pub-id pub-id-type="pmid">30776003</pub-id></element-citation></ref><ref id="B70"><label>70</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deardorff</surname><given-names>WJ</given-names></name><name><surname>Grossberg</surname><given-names>GT</given-names></name></person-group><article-title>Targeting neuroinflammation in Alzheimer&#x02019;s disease: evidence for NSAIDs and novel therapeutics</article-title><source> Expert Rev Neurother</source><year>2017</year><volume>17</volume><fpage>17</fpage><lpage>32</lpage><pub-id pub-id-type="pmid">27293026</pub-id></element-citation></ref><ref id="B71"><label>71</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weinreb</surname><given-names>O</given-names></name><name><surname>Amit</surname><given-names>T</given-names></name><name><surname>Bar-Am</surname><given-names>O</given-names></name><name><surname>Youdim</surname><given-names>MB</given-names></name></person-group><article-title>A novel anti-Alzheimer&#x02019;s disease drug, ladostigil neuroprotective, multimodal brain-selective monoamine oxidase and cholinesterase inhibitor</article-title><source> Int Rev Neurobiol</source><year>2011</year><volume>100</volume><fpage>191</fpage><lpage>215</lpage><pub-id pub-id-type="pmid">21971009</pub-id></element-citation></ref><ref id="B72"><label>72</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weinreb</surname><given-names>O</given-names></name><name><surname>Amit</surname><given-names>T</given-names></name><name><surname>Bar-Am</surname><given-names>O</given-names></name><name><surname>Youdim</surname><given-names>MB</given-names></name></person-group><article-title>Ladostigil: a novel multimodal neuroprotective drug with cholinesterase and brain-selective monoamine oxidase inhibitory activities for Alzheimer&#x02019;s disease treatment</article-title><source> Curr Drug Targets</source><year>2012</year><volume>13</volume><fpage>483</fpage><lpage>494</lpage><pub-id pub-id-type="pmid">22280345</pub-id></element-citation></ref><ref id="B73"><label>73</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soheili</surname><given-names>M</given-names></name><name><surname>Khalaji</surname><given-names>F</given-names></name><name><surname>Mirhashemi</surname><given-names>M</given-names></name><name><surname>Salami</surname><given-names>M</given-names></name></person-group><article-title>The effect of essential oil of Lavandula angustifolia on amyloid beta polymerization: An in vitro study</article-title><source> IJCCE</source><year>2018</year><volume>37</volume><fpage>201</fpage><lpage>207</lpage></element-citation></ref><ref id="B74"><label>74</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zeng</surname><given-names>Q</given-names></name><name><surname>Siu</surname><given-names>W</given-names></name><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Jin</surname><given-names>Y</given-names></name><name><surname>Liang</surname><given-names>S</given-names></name><name><surname>Cao</surname><given-names>M</given-names></name><etal/></person-group><article-title>Autophagy in Alzheimer&#x02019;s disease and promising modulatory effects of herbal medicine</article-title><source> Exp Gerontol</source><year>2019</year><volume>119</volume><fpage>100</fpage><lpage>110</lpage><pub-id pub-id-type="pmid">30710681</pub-id></element-citation></ref><ref id="B75"><label>75</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soheili</surname><given-names>M</given-names></name><name><surname>Rezaei</surname><given-names>M</given-names></name><name><surname>Salami</surname><given-names>M</given-names></name></person-group><article-title>Anti-acetylcholine esterase activity of aqueous extract of lavandula angustifolia and its toxicity effect on HepG2 cell line</article-title><source> Koomesh</source><year>2017</year><volume>19</volume><fpage>263</fpage><lpage>268</lpage></element-citation></ref><ref id="B76"><label>76</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buyukokuroglu</surname><given-names>ME</given-names></name><name><surname>Gepdiremen</surname><given-names>A</given-names></name><name><surname>Hacimuftuoglu</surname><given-names>A</given-names></name><name><surname>Oktay</surname><given-names>M</given-names></name></person-group><article-title>The effects of aqueous extract of Lavandula angustifolia flowers in glutamate-induced neurotoxicity of cerebellar granular cell culture of rat pups</article-title><source> J Ethnopharmacol</source><year>2003</year><volume>84</volume><fpage>91</fpage><lpage>94</lpage><pub-id pub-id-type="pmid">12499081</pub-id></element-citation></ref><ref id="B77"><label>77</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soheili</surname><given-names>M</given-names></name><name><surname>Salami</surname><given-names>M</given-names></name></person-group><article-title>Lavandula angustifolia biological characteristics: An in vitro study</article-title><source> J Cell Physiol</source><year>2019</year><fpage>1</fpage><lpage>7</lpage></element-citation></ref><ref id="B78"><label>78</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hajhashemi</surname><given-names>V</given-names></name><name><surname>Ghannadi</surname><given-names>A</given-names></name><name><surname>Sharif</surname><given-names>B</given-names></name></person-group><article-title>Anti-inflammatory and analgesic properties of the leaf extracts and essential oil of Lavandula angustifolia Mill</article-title><source> J Ethnopharmacol</source><year>2003</year><volume>89</volume><fpage>67</fpage><lpage>71</lpage><pub-id pub-id-type="pmid">14522434</pub-id></element-citation></ref><ref id="B79"><label>79</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hancianu</surname><given-names>M</given-names></name><name><surname>Cioanca</surname><given-names>O</given-names></name><name><surname>Mihasan</surname><given-names>M</given-names></name><name><surname>Hritcu</surname><given-names>L</given-names></name></person-group><article-title>Neuroprotective effects of inhaled lavender oil on scopolamine-induced dementia via anti-oxidative activities in rats</article-title><source> Phytomedicine</source><year>2013</year><volume>20</volume><fpage>446</fpage><lpage>452</lpage><pub-id pub-id-type="pmid">23351960</pub-id></element-citation></ref><ref id="B80"><label>80</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adsersen</surname><given-names>A</given-names></name><name><surname>Gauguin</surname><given-names>B</given-names></name><name><surname>Gudiksen</surname><given-names>L</given-names></name><name><surname>Jager</surname><given-names>AK</given-names></name></person-group><article-title>Screening of plants used in Danish folk medicine to treat memory dysfunction for acetylcholinesterase inhibitory activity</article-title><source> J Ethnopharmacol</source><year>2006</year><volume>104</volume><fpage>418</fpage><lpage>422</lpage><pub-id pub-id-type="pmid">16280217</pub-id></element-citation></ref><ref id="B81"><label>81</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soheili</surname><given-names/></name><name><surname>Salami</surname><given-names>M</given-names></name><name><surname>Haghir</surname><given-names>A</given-names></name><name><surname>Zali</surname><given-names>H</given-names></name><name><surname>Rezaei</surname><given-names>Tavirani M</given-names></name></person-group><article-title>Aqueous extract of Lavandula angustifolia alter protein expression in Alzheimer rats</article-title><source> JRPS</source><year>2014</year><volume>3</volume><fpage>1</fpage><lpage>9</lpage></element-citation></ref><ref id="B82"><label>82</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soheili</surname><given-names>M</given-names></name><name><surname>Tavirani</surname><given-names>MR</given-names></name><name><surname>Salami</surname><given-names>M</given-names></name></person-group><article-title>Clearance of amyloid beta plaques from brain of Alzheimeric rats by Lavandula angustifolia</article-title><source> Neurosc Med</source><year>2012</year><volume>3</volume><fpage>4</fpage><lpage>6</lpage></element-citation></ref><ref id="B83"><label>83</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Watson</surname><given-names>K</given-names></name><name><surname>Hatcher</surname><given-names>D</given-names></name><name><surname>Good</surname><given-names>A</given-names></name></person-group><article-title>A randomised controlled trial of Lavender (Lavandula Angustifolia) and Lemon Balm (Melissa Officinalis) essential oils for the treatment of agitated behaviour in older people with and without dementia</article-title><source> Complement Ther Med</source><year>2019</year><volume>42</volume><fpage>366</fpage><lpage>373</lpage><pub-id pub-id-type="pmid">30670268</pub-id></element-citation></ref><ref id="B84"><label>84</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oskouie</surname><given-names>AA</given-names></name><name><surname>Yekta</surname><given-names>RF</given-names></name><name><surname>Tavirani</surname><given-names>MR</given-names></name><name><surname>Kashani</surname><given-names>MS</given-names></name><name><surname>Goshadrou</surname><given-names>F</given-names></name></person-group><article-title>Lavandula angustifolia effects on rat models of Alzheimer&#x02019;s disease through the investigation of serum metabolic features using NMR metabolomics</article-title><source> Avicenna J Med Biotechnol</source><year>2018</year><volume>10</volume><fpage>83</fpage><lpage>92</lpage><pub-id pub-id-type="pmid">29849984</pub-id></element-citation></ref><ref id="B85"><label>85</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rai</surname><given-names>VK</given-names></name><name><surname>Sinha</surname><given-names>P</given-names></name><name><surname>Yadav</surname><given-names>KS</given-names></name><name><surname>Shukla</surname><given-names>A</given-names></name><name><surname>Saxena</surname><given-names>A</given-names></name><name><surname>Bawankule</surname><given-names>DU</given-names></name><etal/></person-group><article-title>Anti-psoriatic effect of Lavandula angustifolia essential oil and its major components linalool and linalyl acetate</article-title><source> J Ethnopharmacol</source><year>2020</year><volume>261</volume><fpage>113</fpage><lpage>127</lpage></element-citation></ref><ref id="B86"><label>86</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Le</surname><given-names>Bars PL</given-names></name></person-group><article-title>Magnitude of effect and special approach to Ginkgo biloba extract EGb 761 in cognitive disorders</article-title><source> Pharmacopsychiatry</source><year>2003</year><volume>36</volume><fpage>44</fpage><lpage>49</lpage></element-citation></ref><ref id="B87"><label>87</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Napryeyenko</surname><given-names>O</given-names></name><name><surname>Borzenko</surname><given-names>I</given-names></name></person-group><article-title>Ginkgo biloba special extract in dementia with neuropsychiatric features A randomised, placebo-controlled, double-blind clinical trial</article-title><source> Arzneimittelforschung</source><year>2007</year><volume>57</volume><fpage>4</fpage><lpage>11</lpage><pub-id pub-id-type="pmid">17341003</pub-id></element-citation></ref><ref id="B88"><label>88</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thancharoen</surname><given-names>O</given-names></name><name><surname>Limwattananon</surname><given-names>C</given-names></name></person-group><article-title>Ginkgo biloba extract (EGb761), cholinesterase inhibitors, and memantine for the treatment of mild-to-moderate alzheimer&#x02019;s disease: a network meta-analysis</article-title><source> Drugs &#x00026; Aging</source><year>2019</year><volume>36</volume><fpage>435</fpage><lpage>452</lpage><pub-id pub-id-type="pmid">30937879</pub-id></element-citation></ref><ref id="B89"><label>89</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Waleekhachonloet</surname><given-names>O</given-names></name><name><surname>Rattanachotphanit</surname><given-names>T</given-names></name><name><surname>Limwattananon</surname><given-names>P</given-names></name><name><surname>Limpawattana</surname><given-names>P</given-names></name><name><surname>Muller</surname><given-names>WE</given-names></name><name><surname>Eckert</surname><given-names>A</given-names></name><etal/></person-group><article-title>Therapeutic efficacy of the Ginkgo special extract EGb761((R)) within the framework of the mitochondrial cascade hypothesis of Alzheimer&#x02019;s disease</article-title><source> Drugs Aging</source><year>2019</year><volume>20</volume><fpage>173</fpage><lpage>189</lpage></element-citation></ref><ref id="B90"><label>90</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yancheva</surname><given-names>S</given-names></name><name><surname>Ihl</surname><given-names>R</given-names></name><name><surname>Nikolova</surname><given-names>G</given-names></name><name><surname>Panayotov</surname><given-names>P</given-names></name><name><surname>Schlaefke</surname><given-names>S</given-names></name><name><surname>Hoerr</surname><given-names>R</given-names></name></person-group><article-title>Ginkgo biloba extract EGb 761(R), donepezil or both combined in the treatment of Alzheimer&#x02019;s disease with neuropsychiatric features: a randomised, double-blind, exploratory trial</article-title><source> Aging Ment Health</source><year>2009</year><volume>13</volume><fpage>183</fpage><lpage>190</lpage><pub-id pub-id-type="pmid">19347685</pub-id></element-citation></ref><ref id="B91"><label>91</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kehr</surname><given-names>J</given-names></name><name><surname>Yoshitake</surname><given-names>S</given-names></name><name><surname>Ijiri</surname><given-names>S</given-names></name><name><surname>Koch</surname><given-names>E</given-names></name><name><surname>Noldner</surname><given-names>M</given-names></name><name><surname>Yoshitake</surname><given-names>T</given-names></name></person-group><article-title>Ginkgo biloba leaf extract (EGb 761(R)) and its specific acylated flavonol constituents increase dopamine and acetylcholine levels in the rat medial prefrontal cortex: possible implications for the cognitive enhancing properties of EGb 761(R)</article-title><source> Int Psychogeriatr</source><year>2012</year><volume>24</volume><fpage>25</fpage><lpage>34</lpage></element-citation></ref><ref id="B92"><label>92</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shi</surname><given-names>C</given-names></name><name><surname>Zhao</surname><given-names>L</given-names></name><name><surname>Zhu</surname><given-names>B</given-names></name><name><surname>Li</surname><given-names>Q</given-names></name><name><surname>Yew</surname><given-names>DT</given-names></name><name><surname>Yao</surname><given-names>Z</given-names></name><etal/></person-group><article-title>Protective effects of Ginkgo biloba extract (EGb761) and its constituents quercetin and ginkgolide B against beta-amyloid peptide-induced toxicity in SH-SY5Y cells</article-title><source> Chem Biol Interact</source><year>2009</year><volume>181</volume><fpage>115</fpage><lpage>123</lpage><pub-id pub-id-type="pmid">19464278</pub-id></element-citation></ref><ref id="B93"><label>93</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bastianetto</surname><given-names>S</given-names></name><name><surname>Ramassamy</surname><given-names>C</given-names></name><name><surname>Dore</surname><given-names>S</given-names></name><name><surname>Christen</surname><given-names>Y</given-names></name><name><surname>Poirier</surname><given-names>J</given-names></name><name><surname>Quirion</surname><given-names>R</given-names></name></person-group><article-title>The Ginkgo biloba extract (EGb 761) protects hippocampal neurons against cell death induced by beta-amyloid</article-title><source> Eur J Neurosci</source><year>2000</year><volume>12</volume><fpage>1882</fpage><lpage>1890</lpage><pub-id pub-id-type="pmid">10886329</pub-id></element-citation></ref><ref id="B94"><label>94</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>JV</given-names></name><name><surname>Luo</surname><given-names>Y</given-names></name></person-group><article-title>Elevation of oxidative free radicals in Alzheimer&#x02019;s disease models can be attenuated by Ginkgo biloba extract EGb 761</article-title><source> J Alzheimers Dis</source><year>2003</year><volume>5</volume><fpage>287</fpage><lpage>300</lpage><pub-id pub-id-type="pmid">14624024</pub-id></element-citation></ref><ref id="B95"><label>95</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yao</surname><given-names>ZX</given-names></name><name><surname>Han</surname><given-names>Z</given-names></name><name><surname>Drieu</surname><given-names>K</given-names></name><name><surname>Papadopoulos</surname><given-names>V</given-names></name></person-group><article-title>Ginkgo biloba extract (Egb 761) inhibits beta-amyloid production by lowering free cholesterol levels</article-title><source> J Nutr Biochem</source><year>2004</year><volume>15</volume><fpage>749</fpage><lpage>756</lpage><pub-id pub-id-type="pmid">15607648</pub-id></element-citation></ref><ref id="B96"><label>96</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Colciaghi</surname><given-names>F</given-names></name><name><surname>Borroni</surname><given-names>B</given-names></name><name><surname>Zimmermann</surname><given-names>M</given-names></name><name><surname>Bellone</surname><given-names>C</given-names></name><name><surname>Longhi</surname><given-names>A</given-names></name><name><surname>Padovani</surname><given-names>A</given-names></name><etal/></person-group><article-title>Amyloid precursor protein metabolism is regulated toward alpha-secretase pathway by Ginkgo biloba extracts</article-title><source> Neurobiol Dis</source><year>2004</year><volume>16</volume><fpage>454</fpage><lpage>460</lpage><pub-id pub-id-type="pmid">15193301</pub-id></element-citation></ref><ref id="B97"><label>97</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jahanshahi</surname><given-names>M</given-names></name><name><surname>Nikmahzar</surname><given-names>E</given-names></name><name><surname>Yadollahi</surname><given-names>N</given-names></name><name><surname>Ramazani</surname><given-names>K</given-names></name></person-group><article-title>Protective effects of Ginkgo biloba extract (EGB 761) on astrocytes of rat hippocampus after exposure with scopolamine</article-title><source> Anat cell biol</source><year>2012</year><volume>45</volume><fpage>92</fpage><lpage>96</lpage><pub-id pub-id-type="pmid">22822463</pub-id></element-citation></ref><ref id="B98"><label>98</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nikmahzar</surname><given-names>E</given-names></name><name><surname>Jahanshahi</surname><given-names>M</given-names></name><name><surname>Babakordi</surname><given-names>F</given-names></name></person-group><article-title>Ginkgo biloba extract decreases scopolamine-induced congophilic amyloid plaques accumulation in male rat&#x02019;s brain</article-title><source> Jundishapur J Nat Pharm Prod</source><year>2018</year><comment>In Press</comment></element-citation></ref><ref id="B99"><label>99</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shi</surname><given-names>C</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Wu</surname><given-names>F</given-names></name><name><surname>Yew</surname><given-names>DT</given-names></name></person-group><article-title>Ginkgo biloba extract in Alzheimer&#x02019;s disease: from action mechanisms to medical practice</article-title><source> Int J Mol Sci</source><year>2010</year><volume>11</volume><fpage>107</fpage><lpage>123</lpage><pub-id pub-id-type="pmid">20162004</pub-id></element-citation></ref><ref id="B100"><label>100</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Du</surname><given-names>ZY</given-names></name><name><surname>Li</surname><given-names>XY</given-names></name></person-group><article-title>Effects of ginkgolides on interleukin-1, tumor necrosis factor-alpha and nitric oxide production by rat microglia stimulated with lipopolysaccharides in vitro</article-title><source> Arzneimittelforschung</source><year>1998</year><volume>48</volume><fpage>1126</fpage><lpage>1130</lpage><pub-id pub-id-type="pmid">9893925</pub-id></element-citation></ref><ref id="B101"><label>101</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shi</surname><given-names>C</given-names></name><name><surname>Fang</surname><given-names>L</given-names></name><name><surname>Yew</surname><given-names>DT</given-names></name><name><surname>Yao</surname><given-names>Z</given-names></name><name><surname>Xu</surname><given-names>J</given-names></name></person-group><article-title>Ginkgo biloba extract EGb761 protects against mitochondrial dysfunction in platelets and hippocampi in ovariectomized rats</article-title><source> Platelets</source><year>2010</year><volume>21</volume><fpage>53</fpage><lpage>59</lpage><pub-id pub-id-type="pmid">19938886</pub-id></element-citation></ref><ref id="B102"><label>102</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shi</surname><given-names>C</given-names></name><name><surname>Xiao</surname><given-names>S</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Guo</surname><given-names>K</given-names></name><name><surname>Wu</surname><given-names>F</given-names></name><name><surname>Yew</surname><given-names>DT</given-names></name><etal/></person-group><article-title>Ginkgo biloba extract EGb761 protects against aging-associated mitochondrial dysfunction in platelets and hippocampi of SAMP8 mice</article-title><source> Platelets</source><year>2010</year><volume>21</volume><fpage>373</fpage><lpage>379</lpage><pub-id pub-id-type="pmid">20459350</pub-id></element-citation></ref><ref id="B103"><label>103</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>JV</given-names></name><name><surname>Luo</surname><given-names>Y</given-names></name></person-group><article-title>Studies on molecular mechanisms of Ginkgo biloba extract</article-title><source> Appl Microbiol Biotechnol</source><year>2004</year><volume>64</volume><fpage>465</fpage><lpage>472</lpage><pub-id pub-id-type="pmid">14740187</pub-id></element-citation></ref><ref id="B104"><label>104</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rimbach</surname><given-names>G</given-names></name><name><surname>Gohil</surname><given-names>K</given-names></name><name><surname>Matsugo</surname><given-names>S</given-names></name><name><surname>Moini</surname><given-names>H</given-names></name><name><surname>Saliou</surname><given-names>C</given-names></name><name><surname>Virgili</surname><given-names>F</given-names></name><etal/></person-group><article-title>Induction of glutathione synthesis in human keratinocytes by Ginkgo biloba extract (EGb761)</article-title><source> Biofactors</source><year>2001</year><volume>15</volume><fpage>39</fpage><lpage>52</lpage><pub-id pub-id-type="pmid">11673643</pub-id></element-citation></ref><ref id="B105"><label>105</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sasaki</surname><given-names>K</given-names></name><name><surname>Hatta</surname><given-names>S</given-names></name><name><surname>Wada</surname><given-names>K</given-names></name><name><surname>Ueda</surname><given-names>N</given-names></name><name><surname>Yoshimura</surname><given-names>T</given-names></name><name><surname>Endo</surname><given-names>T</given-names></name><etal/></person-group><article-title>Effects of extract of Ginkgo biloba leaves and its constituents on carcinogen-metabolizing enzyme activities and glutathione levels in mouse liver</article-title><source> Life Sci</source><year>2002</year><volume>70</volume><fpage>1657</fpage><lpage>1667</lpage><pub-id pub-id-type="pmid">11991253</pub-id></element-citation></ref><ref id="B106"><label>106</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maclennan</surname><given-names>KM</given-names></name><name><surname>Darlington</surname><given-names>CL</given-names></name><name><surname>Smith</surname><given-names>PF</given-names></name></person-group><article-title>The CNS effects of Ginkgo biloba extracts and ginkgolide B</article-title><source> Prog Neurobiol</source><year>2002</year><volume>67</volume><fpage>235</fpage><lpage>257</lpage><pub-id pub-id-type="pmid">12169298</pub-id></element-citation></ref><ref id="B107"><label>107</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miraj</surname><given-names>S</given-names></name><name><surname>Rafieian</surname><given-names>K</given-names></name><name><surname>Kiani</surname><given-names>S</given-names></name></person-group><article-title>Melissa officinalis A review study with an anti-oxidant prospective</article-title><source> J Evid Based Complementary Altern Med</source><year>2017</year><volume>22</volume><fpage>385</fpage><lpage>394</lpage><pub-id pub-id-type="pmid">27620926</pub-id></element-citation></ref><ref id="B108"><label>108</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>PF</given-names></name><name><surname>Maclennan</surname><given-names>K</given-names></name><name><surname>Darlington</surname><given-names>CL</given-names></name></person-group><article-title>The neuroprotective properties of the Ginkgo biloba leaf: a review of the possible relationship to platelet-activating factor (PAF)</article-title><source> J Ethnopharmacol</source><year>1996</year><volume>50</volume><fpage>131</fpage><lpage>139</lpage><pub-id pub-id-type="pmid">8691847</pub-id></element-citation></ref><ref id="B109"><label>109</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ude</surname><given-names>C</given-names></name><name><surname>Paulke</surname><given-names>A</given-names></name><name><surname>N&#x000f6;ldner</surname><given-names>M</given-names></name><name><surname>Schubert-Zsilavecz</surname><given-names>M</given-names></name><name><surname>Wurglics</surname><given-names>M</given-names></name></person-group><article-title>Plasma and brain levels of terpene trilactones in rats after an oral single dose of standardized Ginkgo biloba extract EGb 761&#x000ae;</article-title><source> Planta Med</source><year>2011</year><volume>77</volume><fpage>259</fpage><lpage>264</lpage><pub-id pub-id-type="pmid">20814851</pub-id></element-citation></ref><ref id="B110"><label>110</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ehsani</surname><given-names>A</given-names></name><name><surname>Alizadeh</surname><given-names>O</given-names></name><name><surname>Hashemi</surname><given-names>M</given-names></name><name><surname>Afshari</surname><given-names>A</given-names></name><name><surname>Aminzare</surname><given-names>M</given-names></name></person-group><article-title>Phytochemical, anti-oxidant and antibacterial properties of Melissa officinalis and Dracocephalum moldavica essential oils</article-title><source> Vet Res Forum</source><year>2017</year><volume>8</volume><fpage>223</fpage><lpage>229</lpage><pub-id pub-id-type="pmid">29085610</pub-id></element-citation></ref><ref id="B111"><label>111</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pereira</surname><given-names>RP</given-names></name><name><surname>Fachinetto</surname><given-names>R</given-names></name><name><surname>de</surname><given-names>Souza Prestes A</given-names></name><name><surname>Puntel</surname><given-names>RL</given-names></name><name><surname>Santos</surname><given-names>da Silva GN</given-names></name><name><surname>Heinzmann</surname><given-names>BM</given-names></name><etal/></person-group><article-title>Anti-oxidant effects of different extracts from Melissa officinalis, Matricaria recutita and Cymbopogon citratus</article-title><source> Neurochem Res</source><year>2009</year><volume>34</volume><fpage>973</fpage><lpage>983</lpage><pub-id pub-id-type="pmid">18853256</pub-id></element-citation></ref><ref id="B112"><label>112</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taiwo</surname><given-names>AE</given-names></name><name><surname>Leite</surname><given-names>FB</given-names></name><name><surname>Lucena</surname><given-names>GM</given-names></name><name><surname>Barros</surname><given-names>M</given-names></name><name><surname>Silveira</surname><given-names>D</given-names></name><name><surname>Silva</surname><given-names>MV</given-names></name><etal/></person-group><article-title>Anxiolytic and antidepressant-like effects of Melissa officinalis (lemon balm) extract in rats: Influence of administration and gender</article-title><source> Indian J Pharmacol</source><year>2012</year><volume>44</volume><fpage>189</fpage><lpage>192</lpage><pub-id pub-id-type="pmid">22529473</pub-id></element-citation></ref><ref id="B113"><label>113</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bounihi</surname><given-names>A</given-names></name><name><surname>Hajjaj</surname><given-names>G</given-names></name><name><surname>Alnamer</surname><given-names>R</given-names></name><name><surname>Cherrah</surname><given-names>Y</given-names></name><name><surname>Zellou</surname><given-names>A</given-names></name></person-group><article-title>In vivo potential anti-Inflammatory activity of Melissa officinalis essential oil</article-title><source> Adv Pharmacol Sci</source><year>2013</year><volume>2013</volume><fpage>1</fpage><lpage>7</lpage></element-citation></ref><ref id="B114"><label>114</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mencherini</surname><given-names>T</given-names></name><name><surname>Picerno</surname><given-names>P</given-names></name><name><surname>Scesa</surname><given-names>C</given-names></name><name><surname>Aquino</surname><given-names>R</given-names></name></person-group><article-title>Triterpene, anti-oxidant, and antimicrobial compounds from Melissa officinalis</article-title><source> J Nat Prod</source><year>2007</year><volume>70</volume><fpage>1889</fpage><lpage>1894</lpage><pub-id pub-id-type="pmid">18004816</pub-id></element-citation></ref><ref id="B115"><label>115</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lopez</surname><given-names>V</given-names></name><name><surname>Martin</surname><given-names>S</given-names></name><name><surname>Gomez-Serranillos</surname><given-names>MP</given-names></name><name><surname>Carretero</surname><given-names>ME</given-names></name><name><surname>Jager</surname><given-names>AK</given-names></name><name><surname>Calvo</surname><given-names>MI</given-names></name></person-group><article-title>Neuroprotective and neurological properties of Melissa officinalis</article-title><source> Neurochem Res</source><year>2009</year><volume>34</volume><fpage>1955</fpage><lpage>1961</lpage><pub-id pub-id-type="pmid">19760174</pub-id></element-citation></ref><ref id="B116"><label>116</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sofowora</surname><given-names>A</given-names></name><name><surname>Ogunbodede</surname><given-names>E</given-names></name><name><surname>Onayade</surname><given-names>A</given-names></name></person-group><article-title>The role and place of medicinal plants in the strategies for disease prevention</article-title><source> Afr J Tradit Complement Altern Med</source><year>2013</year><volume>10</volume><fpage>210</fpage><lpage>229</lpage><pub-id pub-id-type="pmid">24311829</pub-id></element-citation></ref><ref id="B117"><label>117</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Javid</surname><given-names>AZ</given-names></name><name><surname>Haybar</surname><given-names>H</given-names></name><name><surname>Dehghan</surname><given-names>P</given-names></name><name><surname>Haghighizadeh</surname><given-names>MH</given-names></name><name><surname>Mohaghegh</surname><given-names>SM</given-names></name><name><surname>Ravanbakhsh</surname><given-names>M</given-names></name><etal/></person-group><article-title>The effects of Melissa officinalis (lemon balm) in chronic stable angina on serum biomarkers of oxidative stress, inflammation and lipid profile</article-title><source> Asia Pac J Clin Nutr</source><year>2018</year><volume>27</volume><fpage>785</fpage><lpage>791</lpage><pub-id pub-id-type="pmid">30045422</pub-id></element-citation></ref><ref id="B118"><label>118</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bolkent</surname><given-names>S</given-names></name><name><surname>Yanardag</surname><given-names>R</given-names></name><name><surname>Karabulut-Bulan</surname><given-names>O</given-names></name><name><surname>Yesilyaprak</surname><given-names>B</given-names></name></person-group><article-title>Protective role of Melissa officinalis extract on liver of hyperlipidemic rats: a morphological and biochemical study</article-title><source> J Ethnopharmacol</source><year>2005</year><volume>99</volume><fpage>391</fpage><lpage>398</lpage><pub-id pub-id-type="pmid">15946812</pub-id></element-citation></ref><ref id="B119"><label>119</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luno</surname><given-names>V</given-names></name><name><surname>Gil</surname><given-names>L</given-names></name><name><surname>Olaciregui</surname><given-names>M</given-names></name><name><surname>Jerez</surname><given-names>RA</given-names></name><name><surname>de</surname><given-names>Blas I</given-names></name><name><surname>Hozbor</surname><given-names>F</given-names></name></person-group><article-title>Anti-oxidant effect of lemon balm (Melissa officinalis) and mate tea (Ilex paraguensys) on quality, lipid peroxidation and DNA oxidation of cryopreserved boar epididymal spermatozoa</article-title><source> Andrologia</source><year>2015</year><volume>47</volume><fpage>1004</fpage><lpage>1011</lpage><pub-id pub-id-type="pmid">25382606</pub-id></element-citation></ref><ref id="B120"><label>120</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>L</given-names></name><name><surname>Abuhamdah</surname><given-names>S</given-names></name><name><surname>Howes</surname><given-names>MJ</given-names></name><name><surname>Dixon</surname><given-names>CL</given-names></name><name><surname>Elliot</surname><given-names>MS</given-names></name><name><surname>Ballard</surname><given-names>C</given-names></name><etal/></person-group><article-title>Pharmacological profile of essential oils derived from Lavandula angustifolia and Melissa officinalis with anti-agitation properties: focus on ligand-gated channels</article-title><source> J Pharm Pharmacol</source><year>2008</year><volume>60</volume><fpage>1515</fpage><lpage>1522</lpage><pub-id pub-id-type="pmid">18957173</pub-id></element-citation></ref><ref id="B121"><label>121</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kennedy</surname><given-names>DO</given-names></name><name><surname>Scholey</surname><given-names>AB</given-names></name><name><surname>Tildesley</surname><given-names>NT</given-names></name><name><surname>Perry</surname><given-names>EK</given-names></name><name><surname>Wesnes</surname><given-names>KA</given-names></name></person-group><article-title>Modulation of mood and cognitive performance following acute administration of Melissa officinalis (lemon balm)</article-title><source> Pharmacol Biochem Behav</source><year>2002</year><volume>72</volume><fpage>953</fpage><lpage>964</lpage><pub-id pub-id-type="pmid">12062586</pub-id></element-citation></ref><ref id="B122"><label>122</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soodi</surname><given-names>M</given-names></name><name><surname>Naghdi</surname><given-names>N</given-names></name><name><surname>Hajimehdipoor</surname><given-names>H</given-names></name><name><surname>Choopani</surname><given-names>S</given-names></name><name><surname>Sahraei</surname><given-names>E</given-names></name></person-group><article-title>Memory-improving activity of Melissa officinalis extract in naive and scopolamine-treated rats</article-title><source> Res Pharm Sci</source><year>2014</year><volume>9</volume><fpage>107</fpage><lpage>114</lpage><pub-id pub-id-type="pmid">25657779</pub-id></element-citation></ref><ref id="B123"><label>123</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Le&#x0015b;niewicz</surname><given-names>A</given-names></name><name><surname>Jaworska</surname><given-names>K</given-names></name><name><surname>&#x0017b;yrnicki</surname><given-names>W</given-names></name></person-group><article-title>Macro- and micro-nutrients and their bioavailability in polish herbal medicaments</article-title><source> Food Chemistry</source><year>2006</year><volume>99</volume><fpage>670</fpage><lpage>679</lpage></element-citation></ref><ref id="B124"><label>124</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abuhamdah</surname><given-names>S</given-names></name><name><surname>Huang</surname><given-names>L</given-names></name><name><surname>Elliott</surname><given-names>MS</given-names></name><name><surname>Howes</surname><given-names>MJ</given-names></name><name><surname>Ballard</surname><given-names>C</given-names></name><name><surname>Holmes</surname><given-names>C</given-names></name><etal/></person-group><article-title>Pharmacological profile of an essential oil derived from Melissa officinalis with anti-agitation properties: focus on ligand-gated channels</article-title><source> J Pharm Pharmacol</source><year>2008</year><volume>60</volume><fpage>377</fpage><lpage>384</lpage><pub-id pub-id-type="pmid">18284819</pub-id></element-citation></ref><ref id="B125"><label>125</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pereira</surname><given-names>RP</given-names></name><name><surname>Boligon</surname><given-names>AA</given-names></name><name><surname>Appel</surname><given-names>AS</given-names></name><name><surname>Fachinetto</surname><given-names>R</given-names></name><name><surname>Ceron</surname><given-names>CS</given-names></name><name><surname>Tanus-Santos</surname><given-names>JE</given-names></name><etal/></person-group><article-title>Chemical composition, anti-oxidant and anticholinesterase activity of Melissa officinalis</article-title><source> Ind Crops Prod</source><year>2014</year><volume>53</volume><fpage>34</fpage><lpage>45</lpage></element-citation></ref><ref id="B126"><label>126</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hassanzadeh</surname><given-names>G</given-names></name><name><surname>Pasbakhsh</surname><given-names>P</given-names></name><name><surname>Akbari</surname><given-names>M</given-names></name><name><surname>Shokri</surname><given-names>S</given-names></name><name><surname>Ghahremani</surname><given-names>M</given-names></name><name><surname>Amin</surname><given-names>G</given-names></name><etal/></person-group><article-title>Neuroprotective properties of Melissa officinalis L Extract against ecstasy-induced neurotoxicity</article-title><source> Cell J</source><year>2011</year><volume>13</volume><fpage>25</fpage><lpage>30</lpage><pub-id pub-id-type="pmid">23671824</pub-id></element-citation></ref><ref id="B127"><label>127</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qian</surname><given-names>J</given-names></name><name><surname>Chen</surname><given-names>X</given-names></name><name><surname>Chen</surname><given-names>X</given-names></name><name><surname>Sun</surname><given-names>C</given-names></name><name><surname>Jiang</surname><given-names>Y</given-names></name><name><surname>Qian</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Kaempferol reduces K63-linked polyubiquitination to inhibit nuclear factor-kappaB and inflammatory responses in acute lung injury in mice</article-title><source> Toxicol Lett</source><year>2019</year><volume>306</volume><fpage>53</fpage><lpage>60</lpage><pub-id pub-id-type="pmid">30769083</pub-id></element-citation></ref><ref id="B128"><label>128</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kanakis</surname><given-names>CD</given-names></name><name><surname>Tarantilis</surname><given-names>PA</given-names></name><name><surname>Tajmir-Riahi</surname><given-names>HA</given-names></name><name><surname>Polissiou</surname><given-names>MG</given-names></name></person-group><article-title>Crocetin, dimethylcrocetin, and safranal bind human serum albumin: stability and anti-oxidative properties</article-title><source> J Agric Food Chem</source><year>2007</year><volume>55</volume><fpage>970</fpage><lpage>977</lpage><pub-id pub-id-type="pmid">17263501</pub-id></element-citation></ref><ref id="B129"><label>129</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Papandreou</surname><given-names>MA</given-names></name><name><surname>Kanakis</surname><given-names>CD</given-names></name><name><surname>Polissiou</surname><given-names>MG</given-names></name><name><surname>Efthimiopoulos</surname><given-names>S</given-names></name><name><surname>Cordopatis</surname><given-names>P</given-names></name><name><surname>Margarity</surname><given-names>M</given-names></name><etal/></person-group><article-title>Inhibitory activity on amyloid-beta aggregation and anti-oxidant properties of Crocus sativus stigmas extract and its crocin constituents</article-title><source> J Agric Food Chem</source><year>2006</year><volume>54</volume><fpage>8762</fpage><lpage>8768</lpage><pub-id pub-id-type="pmid">17090119</pub-id></element-citation></ref><ref id="B130"><label>130</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moure</surname><given-names>A</given-names></name><name><surname>Franco</surname><given-names>D</given-names></name><name><surname>Sineiro</surname><given-names>J</given-names></name><name><surname>Dominguez</surname><given-names>H</given-names></name><name><surname>Nunez</surname><given-names>MJ</given-names></name><name><surname>Lema</surname><given-names>JM</given-names></name></person-group><article-title>Evaluation of extracts from Gevuina avellana hulls as anti-oxidants</article-title><source> J Agric Food Chem</source><year>2000</year><volume>48</volume><fpage>3890</fpage><lpage>3897</lpage><pub-id pub-id-type="pmid">10995287</pub-id></element-citation></ref><ref id="B131"><label>131</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alavizadeh</surname><given-names>SH</given-names></name><name><surname>Hosseinzadeh</surname><given-names>H</given-names></name></person-group><article-title>Bioactivity assessment and toxicity of crocin: a comprehensive review</article-title><source> Food Chem Toxicol</source><year>2014</year><volume>64</volume><fpage>65</fpage><lpage>80</lpage><pub-id pub-id-type="pmid">24275090</pub-id></element-citation></ref><ref id="B132"><label>132</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Farahmand</surname><given-names>SK</given-names></name><name><surname>Samini</surname><given-names>F</given-names></name><name><surname>Samini</surname><given-names>M</given-names></name><name><surname>Samarghandian</surname><given-names>S</given-names></name></person-group><article-title>Safranal ameliorates anti-oxidant enzymes and suppresses lipid peroxidation and nitric oxide formation in aged male rat liver</article-title><source> Biogerontology</source><year>2013</year><volume>14</volume><fpage>63</fpage><lpage>71</lpage><pub-id pub-id-type="pmid">23179288</pub-id></element-citation></ref><ref id="B133"><label>133</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ochiai</surname><given-names>T</given-names></name><name><surname>Ohno</surname><given-names>S</given-names></name><name><surname>Soeda</surname><given-names>S</given-names></name><name><surname>Tanaka</surname><given-names>H</given-names></name><name><surname>Shoyama</surname><given-names>Y</given-names></name><name><surname>Shimeno</surname><given-names>H</given-names></name></person-group><article-title>Crocin prevents the death of rat pheochromyctoma (PC-12) cells by its anti-oxidant effects stronger than those of alpha-tocopherol</article-title><source> Neurosci Lett</source><year>2004</year><volume>362</volume><fpage>61</fpage><lpage>64</lpage><pub-id pub-id-type="pmid">15147781</pub-id></element-citation></ref><ref id="B134"><label>134</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bisti</surname><given-names>S</given-names></name><name><surname>Maccarone</surname><given-names>R</given-names></name><name><surname>Falsini</surname><given-names>B</given-names></name></person-group><article-title>Saffron and retina: neuroprotection and pharmacokinetics</article-title><source> Vis Neurosci</source><year>2014</year><volume>31</volume><fpage>355</fpage><lpage>361</lpage><pub-id pub-id-type="pmid">24819927</pub-id></element-citation></ref><ref id="B135"><label>135</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ochiai</surname><given-names>T</given-names></name><name><surname>Soeda</surname><given-names>S</given-names></name><name><surname>Ohno</surname><given-names>S</given-names></name><name><surname>Tanaka</surname><given-names>H</given-names></name><name><surname>Shoyama</surname><given-names>Y</given-names></name><name><surname>Shimeno</surname><given-names>H</given-names></name></person-group><article-title>Crocin prevents the death of PC-12 cells through sphingomyelinase-ceramide signaling by increasing glutathione synthesis</article-title><source> Neurochem Int</source><year>2004</year><volume>44</volume><fpage>321</fpage><lpage>330</lpage><pub-id pub-id-type="pmid">14643749</pub-id></element-citation></ref><ref id="B136"><label>136</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mousavi</surname><given-names>SH</given-names></name><name><surname>Tayarani</surname><given-names>NZ</given-names></name><name><surname>Parsaee</surname><given-names>H</given-names></name></person-group><article-title>Protective effect of saffron extract and crocin on reactive oxygen species-mediated high glucose-induced toxicity in PC12 cells</article-title><source> Cell Mol Neurobiol</source><year>2010</year><volume>30</volume><fpage>185</fpage><lpage>191</lpage><pub-id pub-id-type="pmid">19711182</pub-id></element-citation></ref><ref id="B137"><label>137</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Asadi</surname><given-names>F</given-names></name><name><surname>Jamshidi</surname><given-names>AH</given-names></name><name><surname>Khodagholi</surname><given-names>F</given-names></name><name><surname>Yans</surname><given-names>A</given-names></name><name><surname>Azimi</surname><given-names>L</given-names></name><name><surname>Faizi</surname><given-names>M</given-names></name><etal/></person-group><article-title>Reversal effects of crocin on amyloid beta-induced memory deficit: Modification of autophagy or apoptosis markers</article-title><source> Pharmacol Biochem Behav</source><year>2015</year><volume>139</volume><fpage>47</fpage><lpage>58</lpage><pub-id pub-id-type="pmid">26484504</pub-id></element-citation></ref><ref id="B138"><label>138</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Finley</surname><given-names>JW</given-names></name><name><surname>Gao</surname><given-names>S</given-names></name></person-group><article-title>A Perspective on Crocus sativus L (Saffron) Constituent Crocin: A potent water-soluble antioxidant and potential therapy for Alzheimer&#x02019;s disease</article-title><source> J Agric Food Chem</source><year>2017</year><volume>65</volume><fpage>1005</fpage><lpage>1020</lpage><pub-id pub-id-type="pmid">28098452</pub-id></element-citation></ref><ref id="B139"><label>139</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sugiura</surname><given-names>M</given-names></name><name><surname>Shoyama</surname><given-names>Y</given-names></name><name><surname>Saito</surname><given-names>H</given-names></name><name><surname>Abe</surname><given-names>K</given-names></name></person-group><article-title>The effects of ethanol and crocin on the induction of long-term potentiation in the CA1 region of rat hippocampal slices</article-title><source> Jpn J Pharmacol</source><year>1995</year><volume>67</volume><fpage>395</fpage><lpage>397</lpage><pub-id pub-id-type="pmid">7650874</pub-id></element-citation></ref><ref id="B140"><label>140</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Akhondzadeh</surname><given-names>S</given-names></name><name><surname>Fallah-Pour</surname><given-names>H</given-names></name><name><surname>Afkham</surname><given-names>K</given-names></name><name><surname>Jamshidi</surname><given-names>AH</given-names></name><name><surname>Khalighi-Cigaroudi</surname><given-names>F</given-names></name></person-group><article-title>Comparison of Crocus sativus L and imipramine in the treatment of mild to moderate depression: a pilot double-blind randomized trial [ISRCTN45683816]</article-title><source> BMC Complement Altern Med</source><year>2004</year><volume>4</volume><fpage>12</fpage><pub-id pub-id-type="pmid">15341662</pub-id></element-citation></ref><ref id="B141"><label>141</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Batarseh</surname><given-names>YS</given-names></name><name><surname>Bharate</surname><given-names>SS</given-names></name><name><surname>Kumar</surname><given-names>V</given-names></name><name><surname>Kumar</surname><given-names>A</given-names></name><name><surname>Vishwakarma</surname><given-names>RA</given-names></name></person-group><article-title>Crocus sativus extract tightens the blood-brain barrier, reduces amyloid beta load and related toxicity in 5XFAD mice</article-title><source> ACS Chem Neurosci</source><year>2017</year><volume>8</volume><fpage>1756</fpage><lpage>1766</lpage><pub-id pub-id-type="pmid">28471166</pub-id></element-citation></ref><ref id="B142"><label>142</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sahoo</surname><given-names>AK</given-names></name><name><surname>Dandapat</surname><given-names>J</given-names></name><name><surname>Dash</surname><given-names>UC</given-names></name><name><surname>Kanhar</surname><given-names>S</given-names></name></person-group><article-title>Features and outcomes of drugs for combination therapy as multi-targets strategy to combat Alzheimer&#x02019;s disease</article-title><source> J Ethnopharmacol</source><year>2018</year><volume>215</volume><fpage>42</fpage><lpage>73</lpage><pub-id pub-id-type="pmid">29248451</pub-id></element-citation></ref><ref id="B143"><label>143</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ghahghaei</surname><given-names>A</given-names></name><name><surname>Bathaie</surname><given-names>SZ</given-names></name><name><surname>Kheirkhah</surname><given-names>H</given-names></name><name><surname>Bahraminejad</surname><given-names>E</given-names></name></person-group><article-title>The protective effect of crocin on the amyloid fibril formation of Abeta42 peptide in vitro</article-title><source> Cell Mol Biol Lett</source><year>2013</year><volume>18</volume><fpage>328</fpage><lpage>339</lpage><pub-id pub-id-type="pmid">23737042</pub-id></element-citation></ref><ref id="B144"><label>144</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Sun</surname><given-names>C</given-names></name><name><surname>Zheng</surname><given-names>Y</given-names></name><name><surname>Pan</surname><given-names>H</given-names></name><name><surname>Zhou</surname><given-names>Y</given-names></name><name><surname>Fan</surname><given-names>Y</given-names></name></person-group><article-title>The effective mechanism of the polysaccharides from Panax ginseng on chronic fatigue syndrome</article-title><source> Arch Pharm Res</source><year>2014</year><volume>37</volume><fpage>530</fpage><lpage>538</lpage><pub-id pub-id-type="pmid">23963977</pub-id></element-citation></ref><ref id="B145"><label>145</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Remya</surname><given-names>C</given-names></name><name><surname>Dileep</surname><given-names>KV</given-names></name><name><surname>Tintu</surname><given-names>I</given-names></name><name><surname>Variyar</surname><given-names>EJ</given-names></name><name><surname>Sadasivan</surname><given-names>C</given-names></name></person-group><article-title>Flavanone glycosides as acetylcholinesterase inhibitors: computational and experimental evidence</article-title><source> Indian J Pharm Sci</source><year>2014</year><volume>76</volume><fpage>567</fpage><lpage>570</lpage><pub-id pub-id-type="pmid">25593395</pub-id></element-citation></ref><ref id="B146"><label>146</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>YJ</given-names></name><name><surname>Joo</surname><given-names>SC</given-names></name><name><surname>Shi</surname><given-names>J</given-names></name><name><surname>Hu</surname><given-names>C</given-names></name><name><surname>Quan</surname><given-names>S</given-names></name><name><surname>Hu</surname><given-names>J</given-names></name><etal/></person-group><article-title>Metabolic dynamics and physiological adaptation of Panax ginseng during development</article-title><source> Plant Cell Rep</source><year>2018</year><volume>37</volume><fpage>393</fpage><lpage>410</lpage><pub-id pub-id-type="pmid">29150823</pub-id></element-citation></ref><ref id="B147"><label>147</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xiong</surname><given-names>X</given-names></name><name><surname>Huang</surname><given-names>G</given-names></name><name><surname>Huang</surname><given-names>H</given-names></name></person-group><article-title>The anti-oxidant activities of phosphorylated polysaccharide from native ginseng</article-title><source> Int J Biol Macromol</source><year>2019</year><volume>126</volume><fpage>842</fpage><lpage>845</lpage><pub-id pub-id-type="pmid">30610944</pub-id></element-citation></ref><ref id="B148"><label>148</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Choi</surname><given-names>JG</given-names></name><name><surname>Kim</surname><given-names>N</given-names></name><name><surname>Huh</surname><given-names>E</given-names></name><name><surname>Lee</surname><given-names>H</given-names></name><name><surname>Oh</surname><given-names>MH</given-names></name><name><surname>Park</surname><given-names>JD</given-names></name><etal/></person-group><article-title>White ginseng protects mouse hippocampal cells against amyloid-beta oligomer toxicity</article-title><source> Phytother Res</source><year>2017</year><volume>31</volume><fpage>497</fpage><lpage>506</lpage><pub-id pub-id-type="pmid">28112442</pub-id></element-citation></ref><ref id="B149"><label>149</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>HF</given-names></name><name><surname>Li</surname><given-names>Q</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name></person-group><article-title>Long-term ginsenoside administration prevents memory loss in aged female C57BL/6J mice by modulating the redox status and up-regulating the plasticity-related proteins in hippocampus</article-title><source> Neuroscience</source><year>2011</year><volume>183</volume><fpage>189</fpage><lpage>202</lpage><pub-id pub-id-type="pmid">21463662</pub-id></element-citation></ref><ref id="B150"><label>150</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dong</surname><given-names>L</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Lv</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name><name><surname>Jiang</surname><given-names>N</given-names></name><name><surname>Lu</surname><given-names>C</given-names></name><etal/></person-group><article-title>Memory enhancement of fresh ginseng on deficits induced by chronic restraint stress in mice</article-title><year>2019</year><volume>22</volume><fpage>235</fpage><lpage>242</lpage></element-citation></ref><ref id="B151"><label>151</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lyubimov</surname><given-names>II</given-names></name><name><surname>Borzenkov</surname><given-names>VM</given-names></name><name><surname>Chepurnova</surname><given-names>NE</given-names></name><name><surname>Chepurnov</surname><given-names>SA</given-names></name></person-group><article-title>Effect of a polysaccharide fraction of ginseng root on learning and memory in rats (using an active escape response as an example)</article-title><source> Neurosci Behav Physiol</source><year>1997</year><volume>27</volume><fpage>555</fpage><lpage>558</lpage><pub-id pub-id-type="pmid">9353777</pub-id></element-citation></ref><ref id="B152"><label>152</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nishijo</surname><given-names>H</given-names></name><name><surname>Uwano</surname><given-names>T</given-names></name><name><surname>Zhong</surname><given-names>YM</given-names></name><name><surname>Ono</surname><given-names>T</given-names></name></person-group><article-title>Proof of the mysterious efficacy of ginseng: basic and clinical trials: effects of red ginseng on learning and memory deficits in an animal model of amnesia</article-title><source> J Pharmacol Sci</source><year>2004</year><volume>95</volume><fpage>145</fpage><lpage>152</lpage><pub-id pub-id-type="pmid">15215637</pub-id></element-citation></ref><ref id="B153"><label>153</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ye</surname><given-names>R</given-names></name><name><surname>Li</surname><given-names>N</given-names></name><name><surname>Han</surname><given-names>J</given-names></name><name><surname>Kong</surname><given-names>X</given-names></name><name><surname>Cao</surname><given-names>R</given-names></name><name><surname>Rao</surname><given-names>Z</given-names></name><etal/></person-group><article-title>Neuroprotective effects of ginsenoside Rd against oxygen-glucose deprivation in cultured hippocampal neurons</article-title><source> Neurosci Res</source><year>2009</year><volume>64</volume><fpage>306</fpage><lpage>310</lpage><pub-id pub-id-type="pmid">19447300</pub-id></element-citation></ref><ref id="B154"><label>154</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cong</surname><given-names>WH</given-names></name><name><surname>Liu</surname><given-names>JX</given-names></name><name><surname>Xu</surname><given-names>L</given-names></name></person-group><article-title>[Effects of extracts of Ginseng and Ginkgo biloba on hippocampal acetylcholine and monoamines in PDAP-pV717I transgenic mice]</article-title><source> Zhongguo Zhong Xi Yi Jie He Za Zhi</source><year>2007</year><volume>27</volume><fpage>810</fpage><lpage>813</lpage><pub-id pub-id-type="pmid">17969894</pub-id></element-citation></ref><ref id="B155"><label>155</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname><given-names>ZL</given-names></name><name><surname>Chen</surname><given-names>YR</given-names></name><name><surname>Zhou</surname><given-names>C</given-names></name><name><surname>Shi</surname><given-names>JS</given-names></name><name><surname>Duan</surname><given-names>SM</given-names></name></person-group><article-title>[Glutamate-related mechanism of ginsenosides against anoxic-ischemic brain damage]</article-title><source> Zhongguo Ying Yong Sheng Li Xue Za Zhi</source><year>2001</year><volume>17</volume><fpage>105</fpage><lpage>108</lpage><pub-id pub-id-type="pmid">21171388</pub-id></element-citation></ref><ref id="B156"><label>156</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>YC</given-names></name><name><surname>Kim</surname><given-names>SR</given-names></name><name><surname>Markelonis</surname><given-names>GJ</given-names></name><name><surname>Oh</surname><given-names>TH</given-names></name></person-group><article-title>Ginsenosides Rb1 and Rg3 protect cultured rat cortical cells from glutamate-induced neurodegeneration</article-title><source> J Neurosci Res</source><year>1998</year><volume>53</volume><fpage>426</fpage><lpage>432</lpage><pub-id pub-id-type="pmid">9710262</pub-id></element-citation></ref><ref id="B157"><label>157</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ahn</surname><given-names>S</given-names></name><name><surname>Singh</surname><given-names>P</given-names></name><name><surname>Castro-Aceituno</surname><given-names>V</given-names></name><name><surname>Yesmin</surname><given-names>Simu S</given-names></name><name><surname>Kim</surname><given-names>YJ</given-names></name><name><surname>Mathiyalagan</surname><given-names>R</given-names></name><etal/></person-group><article-title>Gold nanoparticles synthesized using Panax ginseng leaves suppress inflammatory - mediators production via blockade of NF-kappaB activation in macrophages</article-title><source> Artif Cells Nanomed Biotechnol</source><year>2017</year><volume>45</volume><fpage>270</fpage><lpage>276</lpage><pub-id pub-id-type="pmid">27611566</pub-id></element-citation></ref><ref id="B158"><label>158</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>SJ</given-names></name><name><surname>Jeong</surname><given-names>HJ</given-names></name><name><surname>Yi</surname><given-names>BJ</given-names></name><name><surname>Kang</surname><given-names>TH</given-names></name><name><surname>An</surname><given-names>NH</given-names></name><name><surname>Lee</surname><given-names>EH</given-names></name><etal/></person-group><article-title>Transgenic Panax ginseng inhibits the production of TNF-alpha, IL-6, and IL-8 as well as COX-2 expression in human mast cells</article-title><source> Am J Chin Med</source><year>2007</year><volume>35</volume><fpage>329</fpage><lpage>339</lpage><pub-id pub-id-type="pmid">17436372</pub-id></element-citation></ref><ref id="B159"><label>159</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Song</surname><given-names>SB</given-names></name><name><surname>Tung</surname><given-names>NH</given-names></name><name><surname>Quang</surname><given-names>TH</given-names></name><name><surname>Ngan</surname><given-names>NT</given-names></name><name><surname>Kim</surname><given-names>KE</given-names></name><name><surname>Kim</surname><given-names>YH</given-names></name></person-group><article-title>Inhibition of TNF-alpha-mediated NF-kappaB transcriptional activity in HepG2 Cells by dammarane-type saponins from Panax ginseng leaves</article-title><source> J Ginseng Res</source><year>2012</year><volume>36</volume><fpage>146</fpage><lpage>152</lpage><pub-id pub-id-type="pmid">23717114</pub-id></element-citation></ref><ref id="B160"><label>160</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>SM</given-names></name></person-group><article-title>Anti-inflammatory effects of ginsenosides Rg5, Rz1 , and Rk1 : inhibition of TNF-alpha-induced NF-kappaB, COX-2, and iNOS transcriptional expression</article-title><source> Phytother Res</source><year>2014</year><volume>28</volume><fpage>1893</fpage><lpage>1896</lpage><pub-id pub-id-type="pmid">25042112</pub-id></element-citation></ref><ref id="B161"><label>161</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kang</surname><given-names>S</given-names></name><name><surname>Kim</surname><given-names>J-E</given-names></name><name><surname>Song</surname><given-names>N</given-names></name><name><surname>Jung</surname><given-names>S</given-names></name><name><surname>Lee</surname><given-names>M</given-names></name><name><surname>Park</surname><given-names>J</given-names></name><etal/></person-group><article-title>The Ginsenoside 20-O-&#x003b2;-D-Glucopyranosyl-20(S)-Protopanaxadiol Induces Autophagy and Apoptosis in Human Melanoma via AMPK/JNK Phosphorylation</article-title><source> PloS one</source><year>2014</year><volume>9</volume><fpage>e104305</fpage><pub-id pub-id-type="pmid">25137374</pub-id></element-citation></ref><ref id="B162"><label>162</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>He</surname><given-names>SB</given-names></name><name><surname>Zhang</surname><given-names>BX</given-names></name><name><surname>Wang</surname><given-names>HH</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Qiao</surname><given-names>YJ</given-names></name></person-group><article-title>[Study on mechanism of Salvia miltiorrhiza treating cardiovascular disease through auxiliary mechanism elucidation system for Chinese medicine]</article-title><source> Zhongguo Zhong Yao Za Zhi</source><year>2015</year><volume>40</volume><fpage>3713</fpage><lpage>3717</lpage><pub-id pub-id-type="pmid">26975090</pub-id></element-citation></ref><ref id="B163"><label>163</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>L</given-names></name><name><surname>Miao</surname><given-names>ZQ</given-names></name><name><surname>Yang</surname><given-names>G</given-names></name><name><surname>Shao</surname><given-names>AJ</given-names></name><name><surname>Huang</surname><given-names>LQ</given-names></name><name><surname>Shen</surname><given-names>Y</given-names></name><etal/></person-group><article-title>[Research wilt disease of Salvia miltiorrhiza and its pathogen]</article-title><source> Zhongguo Zhong Yao Za Zhi</source><year>2013</year><volume>38</volume><fpage>4040</fpage><lpage>4043</lpage><pub-id pub-id-type="pmid">24791484</pub-id></element-citation></ref><ref id="B164"><label>164</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>XZ</given-names></name><name><surname>Qian</surname><given-names>SS</given-names></name><name><surname>Zhang</surname><given-names>YJ</given-names></name><name><surname>Wang</surname><given-names>RQ</given-names></name></person-group><article-title>Salvia miltiorrhiza: A source for anti-Alzheimer&#x02019;s disease drugs</article-title><source> Pharm Biol</source><year>2016</year><volume>54</volume><fpage>18</fpage><lpage>24</lpage><pub-id pub-id-type="pmid">25857808</pub-id></element-citation></ref><ref id="B165"><label>165</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wong</surname><given-names>KK</given-names></name><name><surname>Ho</surname><given-names>MT</given-names></name><name><surname>Lin</surname><given-names>HQ</given-names></name><name><surname>Lau</surname><given-names>KF</given-names></name><name><surname>Rudd</surname><given-names>JA</given-names></name><name><surname>Chung</surname><given-names>RC</given-names></name><etal/></person-group><article-title>Cryptotanshinone, an acetylcholinesterase inhibitor from Salvia miltiorrhiza, ameliorates scopolamine-induced amnesia in Morris water maze task</article-title><source> Planta Med</source><year>2010</year><volume>76</volume><fpage>228</fpage><lpage>234</lpage><pub-id pub-id-type="pmid">19774505</pub-id></element-citation></ref><ref id="B166"><label>166</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>F</given-names></name><name><surname>Zheng</surname><given-names>W</given-names></name><name><surname>Pi</surname><given-names>R</given-names></name><name><surname>Mei</surname><given-names>Z</given-names></name><name><surname>Bao</surname><given-names>Y</given-names></name><name><surname>Gao</surname><given-names>J</given-names></name><etal/></person-group><article-title>Cryptotanshinone protects primary rat cortical neurons from glutamate-induced neurotoxicity via the activation of the phosphatidylinositol 3-kinase/Akt signaling pathway</article-title><source> Exp Brain Res</source><year>2009</year><volume>193</volume><fpage>109</fpage><lpage>118</lpage><pub-id pub-id-type="pmid">18936923</pub-id></element-citation></ref><ref id="B167"><label>167</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname><given-names>WY</given-names></name><name><surname>Jeon</surname><given-names>BH</given-names></name><name><surname>Kim</surname><given-names>YC</given-names></name><name><surname>Lee</surname><given-names>SH</given-names></name><name><surname>Sohn</surname><given-names>DH</given-names></name><name><surname>Seo</surname><given-names>GS</given-names></name></person-group><article-title>PF2401-SF, standardized fraction of Salvia miltiorrhiza shows anti-inflammatory activity in macrophages and acute arthritis in vivo</article-title><source> Int Immunopharmacol</source><year>2013</year><volume>16</volume><fpage>160</fpage><lpage>164</lpage><pub-id pub-id-type="pmid">23583334</pub-id></element-citation></ref><ref id="B168"><label>168</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>YS</given-names></name><name><surname>Zhang</surname><given-names>JT</given-names></name></person-group><article-title>[Anti-oxidative effect of three water-soluble components isolated from Salvia miltiorrhizain vitro]</article-title><source> Yao Xue Xue Bao</source><year>1992</year><volume>27</volume><fpage>96</fpage><lpage>100</lpage><pub-id pub-id-type="pmid">1414377</pub-id></element-citation></ref><ref id="B169"><label>169</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huimin</surname><given-names>Yu LY</given-names></name><name><surname>Hongzu</surname><given-names>Zhou</given-names></name><name><surname>Sichang</surname><given-names>Qu</given-names></name><name><surname>Xianghai</surname><given-names>Zeng</given-names></name><name><surname>Delong</surname><given-names>Zhou</given-names></name><name><surname>Yulian</surname><given-names>Zhou</given-names></name><name><surname>Xinglin</surname><given-names>Li</given-names></name><name><surname>Zhicheng</surname><given-names>Liu</given-names></name></person-group><article-title>Neuroprotection against A&#x003b2;25-35-induced apoptosis by Salvia miltiorrhiza extract in SH-SY5Y cells</article-title><source> Neurochem Int</source><year>2014</year><volume>75</volume><fpage>89</fpage><lpage>95</lpage><pub-id pub-id-type="pmid">24932696</pub-id></element-citation></ref><ref id="B170"><label>170</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mei</surname><given-names>Z</given-names></name><name><surname>Zhang</surname><given-names>F</given-names></name><name><surname>Tao</surname><given-names>L</given-names></name><name><surname>Zheng</surname><given-names>W</given-names></name><name><surname>Cao</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>Z</given-names></name><etal/></person-group><article-title>Cryptotanshinone, a compound from Salvia miltiorrhiza modulates amyloid precursor protein metabolism and attenuates beta-amyloid deposition through upregulating alpha-secretase in vivo and in vitro</article-title><source> Neurosci Lett</source><year>2009</year><volume>452</volume><fpage>90</fpage><lpage>95</lpage><pub-id pub-id-type="pmid">19154776</pub-id></element-citation></ref><ref id="B171"><label>171</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>YW</given-names></name><name><surname>Kim</surname><given-names>DH</given-names></name><name><surname>Jeon</surname><given-names>SJ</given-names></name><name><surname>Park</surname><given-names>SJ</given-names></name><name><surname>Kim</surname><given-names>JM</given-names></name><name><surname>Jung</surname><given-names>JM</given-names></name><etal/></person-group><article-title>Neuroprotective effects of salvianolic acid B on an Abeta25-35 peptide-induced mouse model of Alzheimer&#x0203a;s disease</article-title><source> Eur J Pharmacol</source><year>2013</year><volume>704</volume><fpage>70</fpage><lpage>77</lpage><pub-id pub-id-type="pmid">23461850</pub-id></element-citation></ref><ref id="B172"><label>172</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cao</surname><given-names>YY</given-names></name><name><surname>Wang</surname><given-names>L</given-names></name><name><surname>Ge</surname><given-names>H</given-names></name><name><surname>Lu</surname><given-names>XL</given-names></name><name><surname>Pei</surname><given-names>Z</given-names></name><name><surname>Gu</surname><given-names>Q</given-names></name><etal/></person-group><article-title>Salvianolic acid A, a polyphenolic derivative from Salvia miltiorrhiza bunge, as a multifunctional agent for the treatment of Alzheimer&#x02019;s disease</article-title><source> Mol Divers</source><year>2013</year><volume>17</volume><fpage>515</fpage><lpage>524</lpage><pub-id pub-id-type="pmid">23703159</pub-id></element-citation></ref><ref id="B173"><label>173</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhong</surname><given-names>GX</given-names></name><name><surname>Li</surname><given-names>P</given-names></name><name><surname>Zeng</surname><given-names>LJ</given-names></name><name><surname>Guan</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>DQ</given-names></name><name><surname>Li</surname><given-names>SP</given-names></name></person-group><article-title>Chemical characteristics of Salvia miltiorrhiza (Danshen) collected from different locations in China</article-title><source> J Agric Food Chem</source><year>2009</year><volume>57</volume><fpage>6879</fpage><lpage>6887</lpage><pub-id pub-id-type="pmid">19601629</pub-id></element-citation></ref><ref id="B174"><label>174</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Durairajan</surname><given-names>SS</given-names></name><name><surname>Yuan</surname><given-names>Q</given-names></name><name><surname>Xie</surname><given-names>L</given-names></name><name><surname>Chan</surname><given-names>WS</given-names></name><name><surname>Kum</surname><given-names>WF</given-names></name><name><surname>Koo</surname><given-names>I</given-names></name><etal/></person-group><article-title>Salvianolic acid B inhibits Abeta fibril formation and disaggregates preformed fibrils and protects against Abeta-induced cytotoxicty</article-title><source> Neurochem Int</source><year>2008</year><volume>52</volume><fpage>741</fpage><lpage>750</lpage><pub-id pub-id-type="pmid">17964692</pub-id></element-citation></ref><ref id="B175"><label>175</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname><given-names>L</given-names></name><name><surname>Yu</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>F</given-names></name><name><surname>Chen</surname><given-names>B</given-names></name><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Liu</surname><given-names>G</given-names></name></person-group><article-title>Effects of Salvia miltorrhiza in neural differentiation of rat mesenchymal stem cells with optimized protocol</article-title><source> J Ethnopharmacol</source><year>2011</year><volume>136</volume><fpage>334</fpage><lpage>340</lpage><pub-id pub-id-type="pmid">21549822</pub-id></element-citation></ref><ref id="B176"><label>176</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>CS</given-names></name><name><surname>Chen</surname><given-names>NH</given-names></name><name><surname>Zhang</surname><given-names>JT</given-names></name></person-group><article-title>Protection of PC12 cells from hydrogen peroxide-induced cytotoxicity by salvianolic acid B, a new compound isolated from Radix Salviae miltiorrhizae</article-title><source> Phytomedicine</source><year>2007</year><volume>14</volume><fpage>492</fpage><lpage>497</lpage><pub-id pub-id-type="pmid">17175150</pub-id></element-citation></ref><ref id="B177"><label>177</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>N</given-names></name><name><surname>Kang</surname><given-names>T</given-names></name><name><surname>Xia</surname><given-names>Y</given-names></name><name><surname>Wen</surname><given-names>Q</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Li</surname><given-names>H</given-names></name><etal/></person-group><article-title>Effects of salvianolic acid B on survival, self-renewal and neuronal differentiation of bone marrow derived neural stem cells</article-title><source> Eur J Pharmacol</source><year>2012</year><volume>697</volume><fpage>32</fpage><lpage>39</lpage><pub-id pub-id-type="pmid">23085027</pub-id></element-citation></ref><ref id="B178"><label>178</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>T</given-names></name><name><surname>Jin</surname><given-names>H</given-names></name><name><surname>Sun</surname><given-names>QR</given-names></name><name><surname>Xu</surname><given-names>JH</given-names></name><name><surname>Hu</surname><given-names>HT</given-names></name></person-group><article-title>The neuroprotective effects of tanshinone IIA on beta-amyloid-induced toxicity in rat cortical neurons</article-title><source> Neuropharmacology</source><year>2010</year><volume>59</volume><fpage>595</fpage><lpage>604</lpage><pub-id pub-id-type="pmid">20800073</pub-id></element-citation></ref><ref id="B179"><label>179</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Q</given-names></name><name><surname>Yu</surname><given-names>X</given-names></name><name><surname>Patal</surname><given-names>K</given-names></name><name><surname>Hu</surname><given-names>R</given-names></name><name><surname>Chuang</surname><given-names>S</given-names></name><name><surname>Zhang</surname><given-names>G</given-names></name><etal/></person-group><article-title>Tanshinones inhibit amyloid aggregation by amyloid-beta peptide, disaggregate amyloid fibrils, and protect cultured cells</article-title><source> ACS Chem Neurosci</source><year>2013</year><volume>4</volume><fpage>1004</fpage><lpage>1015</lpage><pub-id pub-id-type="pmid">23506133</pub-id></element-citation></ref><ref id="B180"><label>180</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Joe</surname><given-names>Y</given-names></name><name><surname>Zheng</surname><given-names>M</given-names></name><name><surname>Kim</surname><given-names>HJ</given-names></name><name><surname>Kim</surname><given-names>S</given-names></name><name><surname>Uddin</surname><given-names>MJ</given-names></name><name><surname>Park</surname><given-names>C</given-names></name><etal/></person-group><article-title>Salvianolic acid B exerts vasoprotective effects through the modulation of heme oxygenase-1 and arginase activities</article-title><source> J Pharmacol Exp Ther</source><year>2012</year><volume>341</volume><fpage>850</fpage><lpage>858</lpage><pub-id pub-id-type="pmid">22442118</pub-id></element-citation></ref><ref id="B181"><label>181</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ren</surname><given-names>Y</given-names></name><name><surname>Houghton</surname><given-names>PJ</given-names></name><name><surname>Hider</surname><given-names>RC</given-names></name><name><surname>Howes</surname><given-names>MJ</given-names></name></person-group><article-title>Novel diterpenoid acetylcholinesterase inhibitors from Salvia miltiorhiza</article-title><source> Planta Med</source><year>2004</year><volume>70</volume><fpage>201</fpage><lpage>204</lpage><pub-id pub-id-type="pmid">15114495</pub-id></element-citation></ref><ref id="B182"><label>182</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>DH</given-names></name><name><surname>Jeon</surname><given-names>SJ</given-names></name><name><surname>Jung</surname><given-names>JW</given-names></name><name><surname>Lee</surname><given-names>S</given-names></name><name><surname>Yoon</surname><given-names>BH</given-names></name><name><surname>Shin</surname><given-names>BY</given-names></name><etal/></person-group><article-title>Tanshinone congeners improve memory impairments induced by scopolamine on passive avoidance tasks in mice</article-title><source> Eur J Pharmacol</source><year>2007</year><volume>574</volume><fpage>140</fpage><lpage>147</lpage><pub-id pub-id-type="pmid">17714702</pub-id></element-citation></ref><ref id="B183"><label>183</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Wu</surname><given-names>X</given-names></name><name><surname>Yu</surname><given-names>S</given-names></name><name><surname>Fauzee</surname><given-names>NJ</given-names></name><name><surname>Wu</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>L</given-names></name><etal/></person-group><article-title>Neuroprotective capabilities of Tanshinone IIA against cerebral ischemia/reperfusion injury via anti-apoptotic pathway in rats</article-title><source> Biol Pharm Bull</source><year>2012</year><volume>35</volume><fpage>164</fpage><lpage>170</lpage><pub-id pub-id-type="pmid">22293345</pub-id></element-citation></ref><ref id="B184"><label>184</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qian</surname><given-names>YH</given-names></name><name><surname>Xiao</surname><given-names>Q</given-names></name><name><surname>Xu</surname><given-names>J</given-names></name></person-group><article-title>The protective effects of tanshinone IIA on beta-amyloid protein (1-42)-induced cytotoxicity via activation of the Bcl-xL pathway in neuron</article-title><source> Brain Res Bull</source><year>2012</year><volume>88</volume><fpage>354</fpage><lpage>358</lpage><pub-id pub-id-type="pmid">22498308</pub-id></element-citation></ref><ref id="B185"><label>185</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Man</surname><given-names>Y</given-names></name><name><surname>Yang</surname><given-names>L</given-names></name><name><surname>Zhang</surname><given-names>D</given-names></name><name><surname>Bi</surname><given-names>Y</given-names></name></person-group><article-title>Cryptotanshinone inhibits lung tumor growth by increasing CD4+ T cell cytotoxicity through activation of the JAK2/STAT4 pathway</article-title><source> Oncol Lett</source><year>2016</year><volume>12</volume><fpage>4094</fpage><lpage>4098</lpage><pub-id pub-id-type="pmid">27895777</pub-id></element-citation></ref><ref id="B186"><label>186</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Song</surname><given-names>WZ</given-names></name><name><surname>Cui</surname><given-names>JF</given-names></name><name><surname>Zhang</surname><given-names>GD</given-names></name></person-group><article-title>[Studies on the medicinal plants of Magnoliaceae tu-hou-po of Manglietia]</article-title><source> Yao Xue Xue Bao</source><year>1989</year><volume>24</volume><fpage>295</fpage><lpage>299</lpage><pub-id pub-id-type="pmid">2530753</pub-id></element-citation></ref><ref id="B187"><label>187</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>P</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Zhu</surname><given-names>Y</given-names></name><name><surname>Chen</surname><given-names>S</given-names></name><name><surname>Zhou</surname><given-names>D</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name></person-group><article-title>Honokiol inhibits the inflammatory reaction during cerebral ischemia reperfusion by suppressing NF-kappaB activation and cytokine production of glial cells</article-title><source> Neurosci Lett</source><year>2013</year><volume>534</volume><fpage>123</fpage><lpage>127</lpage><pub-id pub-id-type="pmid">23262090</pub-id></element-citation></ref><ref id="B188"><label>188</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dikalov</surname><given-names>S</given-names></name><name><surname>Losik</surname><given-names>T</given-names></name><name><surname>Arbiser</surname><given-names>JL</given-names></name></person-group><article-title>Honokiol is a potent scavenger of superoxide and peroxyl radicals</article-title><source> Biochem Pharmacol</source><year>2008</year><volume>76</volume><fpage>589</fpage><lpage>596</lpage><pub-id pub-id-type="pmid">18640101</pub-id></element-citation></ref><ref id="B189"><label>189</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoi</surname><given-names>CP</given-names></name><name><surname>Ho</surname><given-names>YP</given-names></name><name><surname>Baum</surname><given-names>L</given-names></name><name><surname>Chow</surname><given-names>AH</given-names></name></person-group><article-title>Neuroprotective effect of honokiol and magnolol, compounds from Magnolia officinalis, on beta-amyloid-induced toxicity in PC12 cells</article-title><source> Phytother Res</source><year>2010</year><volume>24</volume><fpage>1538</fpage><lpage>1542</lpage><pub-id pub-id-type="pmid">20878707</pub-id></element-citation></ref><ref id="B190"><label>190</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>YJ</given-names></name><name><surname>Choi</surname><given-names>DY</given-names></name><name><surname>Yun</surname><given-names>YP</given-names></name><name><surname>Han</surname><given-names>SB</given-names></name><name><surname>Kim</surname><given-names>HM</given-names></name><name><surname>Lee</surname><given-names>K</given-names></name><etal/></person-group><article-title>Ethanol extract of Magnolia officinalis prevents lipopolysaccharide-induced memory deficiency via its antineuroinflammatory and antiamyloidogenic effects</article-title><source> Phytother Res</source><year>2013</year><volume>27</volume><fpage>438</fpage><lpage>447</lpage><pub-id pub-id-type="pmid">22628265</pub-id></element-citation></ref><ref id="B191"><label>191</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>YJ</given-names></name><name><surname>Lee</surname><given-names>YM</given-names></name><name><surname>Lee</surname><given-names>CK</given-names></name><name><surname>Jung</surname><given-names>JK</given-names></name><name><surname>Han</surname><given-names>SB</given-names></name><name><surname>Hong</surname><given-names>JT</given-names></name></person-group><article-title>Therapeutic applications of compounds in the Magnolia family</article-title><source> Pharmacol Ther</source><year>2011</year><volume>130</volume><fpage>157</fpage><lpage>176</lpage><pub-id pub-id-type="pmid">21277893</pub-id></element-citation></ref><ref id="B192"><label>192</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>YK</given-names></name><name><surname>Yuk</surname><given-names>DY</given-names></name><name><surname>Kim</surname><given-names>TI</given-names></name><name><surname>Kim</surname><given-names>YH</given-names></name><name><surname>Kim</surname><given-names>KT</given-names></name><name><surname>Kim</surname><given-names>KH</given-names></name><etal/></person-group><article-title>Protective effect of the ethanol extract of Magnolia officinalis and 4-O-methylhonokiol on scopolamine-induced memory impairment and the inhibition of acetylcholinesterase activity</article-title><source> J Nat Med</source><year>2009</year><volume>63</volume><fpage>274</fpage><lpage>282</lpage><pub-id pub-id-type="pmid">19343477</pub-id></element-citation></ref><ref id="B193"><label>193</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oh</surname><given-names>JH</given-names></name><name><surname>Kang</surname><given-names>LL</given-names></name><name><surname>Ban</surname><given-names>JO</given-names></name><name><surname>Kim</surname><given-names>YH</given-names></name><name><surname>Kim</surname><given-names>KH</given-names></name><name><surname>Han</surname><given-names>SB</given-names></name><etal/></person-group><article-title>Anti-inflammatory effect of 4-O-methylhonokiol, compound isolated from Magnolia officinalis through inhibition of NF-kappaB [corrected]</article-title><source> Chem Biol Interact</source><year>2009</year><volume>180</volume><fpage>506</fpage><lpage>514</lpage><pub-id pub-id-type="pmid">19539808</pub-id></element-citation></ref><ref id="B194"><label>194</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>BH</given-names></name><name><surname>Cho</surname><given-names>JY</given-names></name></person-group><article-title>Anti-inflammatory effect of honokiol is mediated by PI3K/Akt pathway suppression</article-title><source> Acta Pharmacol Sin</source><year>2008</year><volume>29</volume><fpage>113</fpage><lpage>122</lpage><pub-id pub-id-type="pmid">18158873</pub-id></element-citation></ref><ref id="B195"><label>195</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>YR</given-names></name><name><surname>Chen</surname><given-names>HH</given-names></name><name><surname>Ko</surname><given-names>CH</given-names></name><name><surname>Chan</surname><given-names>MH</given-names></name></person-group><article-title>Neuroprotective activity of honokiol and magnolol in cerebellar granule cell damage</article-title><source> Eur J Pharmacol</source><year>2006</year><volume>537</volume><fpage>64</fpage><lpage>69</lpage><pub-id pub-id-type="pmid">16631734</pub-id></element-citation></ref><ref id="B196"><label>196</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>JW</given-names></name><name><surname>Lee</surname><given-names>YK</given-names></name><name><surname>Lee</surname><given-names>BJ</given-names></name><name><surname>Nam</surname><given-names>SY</given-names></name><name><surname>Lee</surname><given-names>SI</given-names></name><name><surname>Kim</surname><given-names>YH</given-names></name><etal/></person-group><article-title>Inhibitory effect of ethanol extract of Magnolia officinalis and 4-O-methylhonokiol on memory impairment and neuronal toxicity induced by beta-amyloid</article-title><source> Pharmacol Biochem Behav</source><year>2010</year><volume>95</volume><fpage>31</fpage><lpage>40</lpage><pub-id pub-id-type="pmid">20004682</pub-id></element-citation></ref><ref id="B197"><label>197</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>YJ</given-names></name><name><surname>Choi</surname><given-names>DY</given-names></name><name><surname>Han</surname><given-names>SB</given-names></name><name><surname>Kim</surname><given-names>YH</given-names></name><name><surname>Kim</surname><given-names>KH</given-names></name><name><surname>Hwang</surname><given-names>BY</given-names></name><etal/></person-group><article-title>Inhibitory effect of ethanol extract of Magnolia officinalis on memory impairment and amyloidogenesis in a transgenic mouse model of Alzheimer&#x02019;s disease via regulating beta-secretase activity</article-title><source> Phytother Res</source><year>2012</year><volume>26</volume><fpage>1884</fpage><lpage>1892</lpage><pub-id pub-id-type="pmid">22431473</pub-id></element-citation></ref><ref id="B198"><label>198</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>YL</given-names></name><name><surname>Lin</surname><given-names>KF</given-names></name><name><surname>Shiao</surname><given-names>MS</given-names></name><name><surname>Chen</surname><given-names>YT</given-names></name><name><surname>Hong</surname><given-names>CY</given-names></name><name><surname>Lin</surname><given-names>SJ</given-names></name></person-group><article-title>Magnolol, a potent anti-oxidant from Magnolia officinalis, attenuates intimal thickening and MCP-1 expression after balloon injury of the aorta in cholesterol-fed rabbits</article-title><source> Biomed Res Int</source><year>2001</year><volume>96</volume><fpage>353</fpage><lpage>363</lpage></element-citation></ref><ref id="B199"><label>199</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>L</given-names></name><name><surname>Chen</surname><given-names>C</given-names></name><name><surname>Cheng</surname><given-names>C</given-names></name><name><surname>Dai</surname><given-names>H</given-names></name><name><surname>Ai</surname><given-names>Y</given-names></name><name><surname>Lin</surname><given-names>C</given-names></name><etal/></person-group><article-title>Evaluation of tyrosinase inhibitory, anti-oxidant, antimicrobial, and antiaging activities of Magnolia officinalis extracts after Aspergillus niger fermentation</article-title><source> BioMed Res Int</source><year>2018</year><volume>2018</volume><fpage>1</fpage><lpage>11</lpage></element-citation></ref><ref id="B200"><label>200</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hou</surname><given-names>YC</given-names></name><name><surname>Chao</surname><given-names>PD</given-names></name><name><surname>Chen</surname><given-names>SY</given-names></name></person-group><article-title>Honokiol and magnolol increased hippocampal acetylcholine release in freely-moving rats</article-title><source> Am J Chin Med</source><year>2000</year><volume>28</volume><fpage>379</fpage><lpage>384</lpage><pub-id pub-id-type="pmid">11154051</pub-id></element-citation></ref><ref id="B201"><label>201</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matsui</surname><given-names>N</given-names></name><name><surname>Takahashi</surname><given-names>K</given-names></name><name><surname>Takeichi</surname><given-names>M</given-names></name><name><surname>Kuroshita</surname><given-names>T</given-names></name><name><surname>Noguchi</surname><given-names>K</given-names></name><name><surname>Yamazaki</surname><given-names>K</given-names></name><etal/></person-group><article-title>Magnolol and honokiol prevent learning and memory impairment and cholinergic deficit in SAMP8 mice</article-title><source> Brain Res</source><year>2009</year><volume>1305</volume><fpage>108</fpage><lpage>117</lpage><pub-id pub-id-type="pmid">19815000</pub-id></element-citation></ref><ref id="B202"><label>202</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ho</surname><given-names>J</given-names></name><name><surname>Hong</surname><given-names>C-</given-names></name></person-group><article-title>Cardiovascular protection of magnolol: Cell-type specificity and dose-related effects</article-title><source> J biomed sci</source><year>2012</year><volume>19</volume><fpage>70</fpage><pub-id pub-id-type="pmid">22849814</pub-id></element-citation></ref></ref-list></back></article>